Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home
Top
(S)-crizotinib
0-Hydroxyusamb..
10'-hydroxyusa..
10-hydroxyusam..
12α-epi-millet..
2'-o-ribose me..
2-deoxy-D-gluc..
22-hydroxyhopa..
24-dimethylene..
3'-(3-methyl-2..
3,3'-diindolyl..
3-O-β-D-glucos..
4'-fluorouridine
4-hydroxy-2-no..
4-hydroxycordoin
5-chloro-omega..
6-azauridine
6-Deaminosinef..
6-gingerol
6-oxoisoiguest..
6-paradol
7-hydroxystaur..
76clAbs
8G3
A3659
A3777
A6-001
abacavir
abatacept
abemaciclib
abivertinib
abrisapogenol G
abrusoside A
abyssinone II
acarbose
acetaldehyde
acetoside
acetylcysteine
acyclovir
adamumab
adefovir
afatinib
aflatoxin-b1
Aframomum mele..
afzelin
agaricus bispo..
agathisflavone
agomelatine
AGP-14
AGP-15
AICA-ribonucle..
ajugol
alantolactone
alitretinoin
allicin
allopurinol
alloyohimbine ..
aloe emodin
aloenin
aloeresin D
aloesin
aloevera
aloin
alpha-L-arabin..
alpha-tocopherol
alphaspinasterol
AM1241
amantadine
Amaranthin
amentoflavone
amiodarone
amitriptyline
amlodipine
amodiaquine
amodiaquine di..
amoxicillin
amphotericin B
amprenavir
Amygdalin
amyrin
anacardic acid
anakinra
anastrozole
anatibant
andrographis p..
Andrographolide
Anhydrosafflor..
Anisodamine
anthraquinones
apalutamide
apigenin
apiin
apilimod
apixaban
APN01
aprotinin
arbidol
ARD-61
arginine
argiprestocin
aripiprazole
Arq Ajīb
ARRY-797
arteannuin
arteether
Artemisia annua
artesunate
artesunate/pyr..
arvoside
arylazothiazol..
ASC09
Ashwagandha
asparagamine A
asteriscunolid..
astragalin
Astragaloside IV
AT-527
atazanavir
atorvastatin
atovaquone
Atractylenolid..
avdoralimab
Aviptadil
Ayurcov
azacitidine
azadirachtani
azadirachtin-H
azadirachtin-I
azadirachtin-Q
azathioprine
AZD7442
Azelastine
azithromycin
Azvudine
bafetinib
baicalein
Baicalin
balicatib
baloxavir marb..
balsaminone A
baricitinib
batatasin I
bavachin
BB-Cl-amidine
beauvericin
bedaquiline
belinostat
bemcentinib
benazepril
benserazide
Benzoic acid
benzopyrene
benzoylgedunin
berbamine
berberine
bergamottin
berzosertib
beta-escin
betamethasone
betulin
bevacizumab
bezafibrate
bicalutamide
bicuculline
Biflavone
bifonazole
Biorobin
Bis-demethoxyc..
bis-thiadiazoles
biscryptolepine
bisdemethoxycu..
Bismuth Subsal..
bisoprolol
bisphenol-a
BLD-2660
blue light
boceprevir
boesenbergia r..
boron citrate
bortezomib
bosutinib
boswellic acids
brazilin
breathing exer..
brequinar
brexanolone
BRII-196/BRII-..
brilacidin
bromelain
bromocriptine
Broussoflavan A
brusatol
bucillamine
bucladesine
bufalin
bufotaline
bupropion
buspirone
buthionine-sul..
C135-LS/C144-LS
C60 fullerene
CAA-0225
cadmium-chloride
caffeic acid
caffeine
Calarene
calcitriol
calendula glyc..
callophysin A
calpain inhibi..
calpeptin
camellia sinen..
camostat
campesterol
camptothecin
canakinumab
canderastan ci..
cannabidinol
capastat
capsaicin
captopril
carbamazepine
carbetocin
carbon-tetrach..
carragelose
carrimycin
carvedilol
catechin
cathepsin Inhi..
caulerpin
CD24Fc
cefixime
cefpiramide
cefpodoxime
celecoxib
cephalosporin ..
cepharanthine
cetirizine
cetylpyridiniu..
CF101
chebulagic acid
chebulinic acid
chloramphenicol
chlorhexidine
chlorine dioxide
Chlorogenic acid
chlorpheniramine
chlorpromazine
chlorprothixene
chlortalidone
ChloViD2020
chrysin
Chyawanprash
ciclesonide
cidofovir
CIGB-325
ciglitazone
cilazapril
cinnamaldehyde
Cinnamic amides
cinobufagin
ciprofloxacin
cisplatin
Citronellol
Cl-amidine
clazakizumab
clemastine fum..
clevudine
clodronic-acid
clofazimine
clofibrate
clofoctol
clonazepam
clonidine
clopidogrel
clozapine
CLSP-2
cobicistat
coclaurine
Codivir
colforsin
colistin
concanamycin A
coniferyl alde..
conivaptan
copper(II) glu..
coptisine
cordifoliside
cordycepin
corilagin
cornuside
corticosterone
Cosmosiin
coumarin
coumaroylquini..
coumestrol
COVI-AMG/COVI-..
COVI-GUARD
CoViTris2020
CpdD
crambescidin 786
crambescidin 826
crinine
crizanlizumab
crocin
cryptomerin
cryptomisrine
cryptophycin 1
cryptophycin 52
Cryptoquindoline
cryptospirolep..
cryptotanshinone
crytospirolepine
CT-P59
CTB-ACE2 gum
Cucurbitacin G..
cyanidin
cyanidin 3-O-r..
cyanidin 5-O-β..
cyanidin-3-O-g..
cyanin
cycloeucalenol
cycloheximide
cyclophosphamide
cyclosporine
cynarin
CYNK-001
cysteamine
cystodion E
cytarabine
cytochalasin Z8
D-α-tocopherol..
daclatasvir
dactinomycin
daidzein
danoprevir
darolutamide
darunavir
Darunavir Etha..
dasatinib
Daturaolone
daunorubicin
deacetylnomilin
decitabine
deguelin
dehydrocostus ..
dehydrodiisoeu..
delavirdine
Delphinidin
delphinidin 3-..
demethoxycurcu..
Demethylzeylas..
demoxytocin
deoxycylindros..
deoxynortrypto..
deserpidine
desloratadine
dexamethasone
dexanabinol
dexchlorphenir..
Dfo
diammonium gly..
Diarylheptanoids
diazepam
dichloroacetic..
diclofenac
didanosine
Dieckol
dieldrin
diethylstilbes..
difeterol
Digitoxigenine
digoxin
dihydroartemis..
dihydroartemis..
dihydrocelastrol
dihydroergotam..
dihydrokaempfe..
dihydromyricetin
Dihydronitidine
dihydroquercetin
Dimethyl Sulfo..
dimethylnitros..
dinaciclib
dinoprost
diosbulbinosid..
diosmin
diphenhydramine
dipyridamole
disulfiram
dithymoquinone
dlunarizine
DMP 777
DNL758
dolastatin
dolutegravir
domperidone
donepezil
doramectin
doxazosin
doxorubicin
doxycycline
duloxetine
ebastine
ebselen
echinacea purp..
eckol
ecteinascidin
eculizumab
EK1C4
ellagic acid
ellipticine
emetine
emodin
emodine 8-gluc..
emtricitabine
enalapril
engineered ACE2
enoxaparin
entecavir
enterodiol
entinostat
enzalutamide
ephedrine
epicatechin
epigallocatechin
eprinomectin
ergotamine
eriodictyol
erlotinib
erythromycin
estradiol
estragole
estriol
estrogen
estrone
estrone-2,3-qu..
etacrynic acid
etanercept
ethinyl-estrad..
ethoxzolamide
ethyl lauroyl ..
ethynodiol dia..
Etodolac
etoposide
etravirine
Euchrenone
euchrestaflava..
eugenol
everolimus
evodiamine
Evusheld
examorelin
EXO-CD24
ezetimibe
fangchinoline
faradiol
Farnesiferol B
FBR-002
Febcin
fedratinib
fenofibrate
fenretinide
Ferrocene deri..
ferulic acid
finasteride
fingolimod
flavanthrin
flecainide
flemiflavanone D
FLOVID-20
fluorescein
fluorouracil
fluoxetine
flutamide
fluvastatin
folic acid
Forsythoside A
Forsythoside I
fostamatinib
fucoidan
fulvestrant
fumonisin-b1
furan
fusicoccin
Galangin
galanthamine
galidesivir
Gallic acid
gallocatechin
Gancao-Banxia
ganciclovir
gardenin A
gastrodin
GB-1
GC-373
GC-376
gefitinib
gemcitabine
genistein
genz-123346
gigantol
giloy
gilteritinib
gimsilumab
ginger
gingerol
ginkgetin
gitoformate
glabridin
glabrone
glafenine
glecaprevir
glucosamine
glutathione
glycine
glycycrrhizin
glycyrrhiza gl..
glycyrrhizin
GMC 2-113
GMC 2-29
GR 127935
gramine
grazopavir
grazoprevir
Green Tea
Griffithsin
GRL0617
GW 803430
gycyrrhizin
halichondrin
haloperidol
hanshi zufei
harsingar
hederagenin
heparin
herbacetin
Hesperidin
hinokiflavone
hinokitiol
homo-harringto..
homoharrington..
honey
hruceine A
Huashibaidu
hydralazine
hydrochlorothi..
hydrocortisone
hydrogen perox..
hydroquinone
hydroxycarbamide
hydroxyurea
hydroxyzine
Hygromycin B
hypericin
hyperin
hypochlorous a..
ibrutinib
ibuprofen
ichangin
IFN-β1a
IFN-β1b
ifosfamide
IFX-1
iguesterin
IKK-2 inhibito..
ilexin B
ilexsaponin B2
imatinib
immunoglobulin
imperialine
indapamide
Indigo
indigo blue
indinavir
indisulam
indole-3-carbi..
Indomethacin
infliximab
INM005
interferon bet..
interferon bet..
interferon-λ
interleukin-2
ionomycin
ipratropium br..
irinotecan
Irisolidone
Isatis indigot..
isoalantolactone
isobavachalcone
isocarboxazide
isocolumbin
Isoferulic acid
isoginkget
isoiguesterin
isoliensinine
isoprinosine
isoquercitrin
isorhamnetin
isorhamnetin-3..
isorientin
isosilybin B
isotretinoin
IT1t dihydroch..
jakotinib
Jing Si Herbal..
Jinhua Qinggan
JMX0286
JMX0301
JMX0941
JQ1
JS016
JT001 (VV116)
JTV519 hemifum..
Kabasura Kudin..
kaempferol
kaempferol sul..
kaempferol-3-O..
kakkontokasenk..
Kalmegh
kanamycin
karanjin
keigairengyoto
ketazolam
kinetin
Kobophenol A
kushenol-w
L-arginine
L-glutamine
L-Lysine
laminarin
lanadelumab
lanreotide
Las 51620429
Las 51620435
lauruside
Lectin
ledipasvir
lefamulin
leflunomide
lentinula edodes
lenzilumab
leronlimab
leucal
leucopelargoni..
Levamisole
levetiracetam
levilimab
levofloxacin
Levomefolic
Lianhua Qingwen
licoleafol
liensinine
lignans
Limonene
limonin
linagliptin
liquiritin
lisinopril
lithium-chloride
lomitapide
lonafarnib
loniflavone
loperamide
lopinavir
loratadine
lorazepam
losartan
Lu AE58054
lumacaftor
Lung Cleansing..
lupeol
lupinifolin
lurasidone
lutein
Luteolin
LY2835219
LY3127804
lycorine
lycorine hydro..
lypressin
magnoflorine
magnolol
mallotophilipp..
mangiferin
manidipine
Manuka honey
Maoto
MAPK13-IN-1
maprotiline
masitinib
Maslinic acid
MCOPPB
MDL-28170
Mearnsitrin
medicagol
medicarpin
mefloquine
melitracen
meloxicam
meplazumab
mercaptopurine
MesenCure
metformin glyc..
methapyrilene
methdilazine
methimazole
methotrexate
methotrimepraz..
methoxychlor
Methyl rosmari..
methylene blue
Methylephedrine
methylnaltrexone
methylochnafla..
methylpredniso..
metoclopramide
mevalonic acid
MFCD00832476
MFCD02180753
MI-1851
micafungin
mifepristone
milk thistle
miricetine-3-g..
mitomycin C
MK-2206
ML414
MLN-3897
momordinic
monolaurin
montelukast
morelloflavone
morin
morusin
moxidectin
moxifloxacin
MPI43
MPI44
MPI46
MPro 13b
MPro N3
MUC1
multimeric sol..
mycophenolic a..
myricentin
myricetin
myricitrin
myristicin
N-acetylglucos..
N-methylspiper..
nabiximols
nafamostat
naltrindole is..
naphthoquine
naproxen
narciclasine
narcissin
naringen
naringenin
naringin
natamycin
natto extract
neem
negillicine
nelfinavir
Neochlorogenic..
neomycin
niacinamide
niclosamide
nicotiflorin
nicotinamide m..
nicotine
nictoflorin
nifedipine
nigricanoside A
nigricanoside B
nilotinib
nimbin
nimesulide
nitisinone
nitrogen
nitroglycerin
nivolumab
nomilin
NOQ19
norepinephrine
norquinadoline A
NSC 33994
nuciferine
nystatin
obacunone
obtivo
ochratoxin-a
okadaic acid
olanzapine
oleanderolide
oleandrin
oleoylethanola..
oleuropein
omalizumab
ombitasvir
Omega 3
omeprazole
omipalisib
ONO 5334
ononin
opaganib
oridonin
ornipressin
Oroxylin A
orphenadrine
oseltamivir
osimertinib
otosiban
ouabain
oxazepam
oxidopamine
oxygen-ozone i..
oxytetracycline
ozone therapy
P-57AS3
p-coumaric acid
p-coumaroyltri..
paclitaxel
pacritinib
palmitoylated ..
pamapimod
panduratin A
panobinostat
paritaprevir
paroxetine
PC000361
PC000550
PC000558
PC000573
pectolinarin
pedunculoside
pegylated inte..
peimisine
pemziviptadil
penciclovir
pentachlorophe..
pentamidine
pentosan polys..
pentoxifylline
perfenazine
perilla aldehyde
perillyl alcohol
perindopril
periplocoside
petunidin 3,5-..
phenethyl-isot..
phenformin
phenytoin
phillyrin
phosphodiester..
pHOXWELL
phthalocyanine
Phyllaemblinol
phylloflavan
pibrentasvir
piclidenoson
picotamide
pictilisib
pifithrin
pilaralisib
pilocarpine
pioglitazone
piperacetazine
piperaquine
piperine
Piperolactam A
pirfenidone
pirinixic acid
piroxicam
pleurotus ostr..
plicamycin
podocarpusflav..
Poly-hydroxyfl..
Poly-methoxyfl..
Polyketide iso..
polymyxin B1
pomegranate
pomegranate pe..
pomiferin
Porphyridium sp.
pramipexole
Pranayama
pranlukast
pravastatin
prednisolone
prednisone
pristimerin
probenecid
proceragenin A
procyanidin
procynidin B1
progesterone
proglumetacin
proguanil
propadimine
propolis
propolis sulab..
propranolol
propylthiouracil
protopanaxatriol
Pseudoephedrine
Psiadia punctu..
psoralidin
PTC299
pterostilbene
puerarin
punicalin
Pyramax
pyrazolanthrone
pyrimethamine
pyrimidine
pyronaridine
Q34
quercetagetin
quercetin 3-O-..
quercetin-3-O-..
Quinadoline
quinadoline B
quinine
radotinib
ralimetinib
raloxifene
raltegravir
ramelteon
ramipril
ranitidine
rapamycin
ravulizumab
RD-X19
regdanvimab
Rejuveinix
rescimetol
reserpine
resveratrol
rhein
Rheum palmatum
Rhizoma Cibotii
rhodionin
rhoifolin
ribavirin
riboflavin
rifapentine
rimonabant
ritonavir
rivaroxaban
roburicacid
robustaflavone
rosiglitazone
rosoxacin
rosuvastatin
rotenone
rutaecarpine
rutin
ruxolitinib
S-15176 difuma..
S-217622
S1RA
SAB-185
sabizabulin
saffron
saline
salinomycin
Saliravira
Salvianolic acid
salvianolic ac..
saquanivir
saquinavir
saracatinib
saRBD-1
SARS-BLOCK
sarsasapogenin
SB 271046
SB203580
scedapin C
sciadopitysin
scutellarein
scutellaria ba..
scutellarin
sea cucumber s..
selamectin
selenium
Sepiapterin
Seraph 100 Mic..
serratiopeptid..
sertraline
sesamin
sesaminol
sesamolin
sesamolinol
shallot
shogaol
shosaikotokaki..
Shuang Huang L..
SI-F019
silibinin
Silmitasertib
silodosin
siltuximab
silybin
silydianin
simeprevir
simvastatin
sinapoyl D glu..
Sinigrin
sirolimus
sitagliptin
sitosterol
SN00074072
SN00162745
SN00334175
SNG001
sodium bicarbo..
sofosbuvir
solanine
somatotropin
somniferine
sophaline
sorafenib
sotalol
sparfloxacin
Speciophylline
spermidine
spermine
spiperone
spironolactone
Spirulina
stenoparib
STF-62247
strictinin
strychnine
strychnopentam..
stychnopentamine
sulfasalazine
sulindac
sunitinib
suramin
swertianolin
tacrolimus
tadalafil
tafenoquine
tamibarotene
tamoxifen
tamsulosin
tannic acid
tanshinone IIA
tanshinone-I
Tanshinones
taraxerol
taxifolin
tazarotene
TBAJ-876
TCID
TCM5280343
TCM5280445
TCM5280805
TCM5280863
TCM5458190
telmisartan
temazepam
teniposide
Tenofovir
tenofovir alaf..
tenofovir diso..
terbinafine
terflavin A
testosterone
Tetra-O-galloy..
tetrachloroeth..
tetracycline
tetrandrine
Tetrodotoxin
thalidomide
thalimonine
thapsigargin
theaflavin
theaflavin-3,3..
theophylline
thiamazole
thiamine
thioguanine
thioridazine HCl
thiostrepton
thymic peptides
thymoquinone
tideglusib
tiliroside
tingenone
tinocordiside
tinofoviralafe..
tipifarnib
tipranavir
tiracizine
tirucallin A
TJ003234
tocilizumab
tofacitinib
tofacitinibfed..
Tollovir
tolterodine
tomatidine
topotecan
Torchnil
toremifene
torin-2
torososide B
Torreya nucifera
tozumab
TPNT1
Tranilast
tretinoin
triamcinolone
triamterene
tributyltin
trichloroethyl..
trichostatin-a
triclosan
trifluomeprazi..
trifluoperazin..
trifucol
TriSb92
troglitazone
tunicamycin
tyrphostin-AG-..
ubiquinone
Uncaric acid
Uncarine F
UNII-O9H5KY11SV
urethane
Urso-deoxychol..
ursolic acid
urtica dioica ..
usambarensine
usararotenoid A
valaciclovir
valdecoxib
valproic acid
valsartan
vancomycin
vanillin
VBY-825,
velpatasvir
venlafaxine
verapamil
veratridine
verbascoside
vicenin
vinblastine
vincapusine
vincristine
viomycin
VIR-7831/VIR-7..
virgin coconut..
vitamin B12
vitamin B9
vitamin E
vitamin K1
vitamin K2
vitexin
vorinostat
VPS34-IN1
VUWCOV059
VUWCOV270
VWCOV267
warfarin
Withanolide A
withanolide B
Withanone
withanoside V
wortmannin
Xanthoangelol E
Xuanfeibaidu
Xuebijing
xylitol
yohimibine
Z LVG CHN2
Z-FA-FMK
Z-gly-leu-phec..
zabofoxacin
zafirlukast
zanamivir
ZBC260
zearalenone
zidovudine
zinc pyrithione
ZINC000013444414
ZINC000027215482
ZINC000137976768
ZINC000143375720
ZINC000252515584
ZINC000253504766
ZINC000253504770
ZINC02111387
ZINC02122196
ZINC03231196
ZINC04090608
ZINC12006217
ZINC32960814
zingeberene
zingiber offic..
ZINV03977803
ziprasidone
ZnONPs
ZnSeC-Humicin
α-hederin
α-lactalbumin
α-mangostin
β-D-galactose
β-glucan
β-sitosterol
γ-mangostin
δ-viniferin
Δ9-tetrahydroc..
κ-carrageenan
λ-carrageenan

Feedback
Home   COVID-19 treatment studies  COVID-19 treatment studies  COVID-19 studies   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Melatonin (meta)
Aspirin (meta) Metformin (meta)
Bamlaniv../e.. (meta) Molnupiravir (meta)
Bebtelovimab (meta) N-acetylcys.. (meta)
Bromhexine (meta) Nigella Sativa (meta)
Budesonide (meta) Nitazoxanide (meta)
Cannabidiol (meta) Nitric Oxide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)
Lactoferrin (meta)
Other Treatments Global Adoption
Early treatments for COVID-19
Home   
Share  
Tweet
  Global AdoptionAdoption
  Submit FeedbackFeedback
1,226 other treatments reported as potentially beneficial for early treatment of COVID-19 in studies. We have not reviewed these studies.
Sort by number of studies   Sort alphabetically   Submit updates
(S)-crizotinib   0-Hydroxyusambarensine   10'-hydroxyusambaresine   10-hydroxyusambarensine   12α-epi-milletosin   2'-o-ribose methyltransferase   2-deoxy-D-glucose   22-hydroxyhopan3-one   24-dimethylene cycloartenol   3'-(3-methyl-2-butenyl)-4'-O-β-d-glucopyranosyl-4,2'-dihydroxychalcone   3,3'-diindolylmethane   3-O-β-D-glucoside   4'-fluorouridine   4-hydroxy-2-nonenal   4-hydroxycordoin   5-chloro-omega-hydroxy-1-O-methylemodin   6-azauridine   6-Deaminosinefungin   6-gingerol   6-oxoisoiguesterin   6-paradol   7-hydroxystaurosporine   76clAbs   8G3   A3659   A3777   A6-001   abacavir   abatacept   abemaciclib   abivertinib   abrisapogenol G   abrusoside A   abyssinone II   acarbose   acetaldehyde   acetoside   acetylcysteine   acyclovir   adamumab   adefovir   afatinib   aflatoxin-b1   Aframomum melegueta   afzelin   agaricus bisporus   agathisflavone   agomelatine   AGP-14   AGP-15   AICA-ribonucleotide   ajugol   alantolactone   alitretinoin   allicin   allopurinol   alloyohimbine gummadiol   aloe emodin   aloenin   aloeresin D   aloesin   aloevera   aloin   alpha-L-arabinopyranose   alpha-tocopherol   alphaspinasterol   AM1241   amantadine   Amaranthin   amentoflavone   amiodarone   amitriptyline   amlodipine   amodiaquine   amodiaquine dihydrochloride   amoxicillin   amphotericin B   amprenavir   Amygdalin   amyrin   anacardic acid   anakinra   anastrozole   anatibant   andrographis paniculata   Andrographolide   Anhydrosafflor yellow B   Anisodamine   anthraquinones   apalutamide   apigenin   apiin   apilimod   apixaban   APN01   aprotinin   arbidol   ARD-61   arginine   argiprestocin   aripiprazole   Arq Ajīb   ARRY-797   arteannuin   arteether   Artemisia annua   artesunate   artesunate/pyronaridine   arvoside   arylazothiazolimines   ASC09   Ashwagandha   asparagamine A   asteriscunolide D   astragalin   Astragaloside IV   AT-527   atazanavir   atorvastatin   atovaquone   Atractylenolide III   avdoralimab   Aviptadil   Ayurcov   azacitidine   azadirachtani   azadirachtin-H   azadirachtin-I   azadirachtin-Q   azathioprine   AZD7442   Azelastine   azithromycin   Azvudine   bafetinib   baicalein   Baicalin   balicatib   baloxavir marboxil   balsaminone A   baricitinib   batatasin I   bavachin   BB-Cl-amidine   beauvericin   bedaquiline   belinostat   bemcentinib   benazepril   benserazide   Benzoic acid   benzopyrene   benzoylgedunin   berbamine   berberine   bergamottin   berzosertib   beta-escin   betamethasone   betulin   bevacizumab   bezafibrate   bicalutamide   bicuculline   Biflavone   bifonazole   Biorobin   Bis-demethoxycurcumin   bis-thiadiazoles   biscryptolepine   bisdemethoxycurcumin   Bismuth Subsalicylate   bisoprolol   bisphenol-a   BLD-2660   blue light   boceprevir   boesenbergia rotunda   boron citrate   bortezomib   bosutinib   boswellic acids   brazilin   breathing exercises   brequinar   brexanolone   BRII-196/BRII-198   brilacidin   bromelain   bromocriptine   Broussoflavan A   brusatol   bucillamine   bucladesine   bufalin   bufotaline   bupropion   buspirone   buthionine-sulfoximine   C135-LS/C144-LS   C60 fullerene   CAA-0225   cadmium-chloride   caffeic acid   caffeine   Calarene   calcitriol   calendula glycoside B   callophysin A   calpain inhibitor I   calpeptin   camellia sinensis   camostat   campesterol   camptothecin   canakinumab   canderastan cilexetil   cannabidinol   capastat   capsaicin   captopril   carbamazepine   carbetocin   carbon-tetrachloride   carragelose   carrimycin   carvedilol   catechin   cathepsin Inhibitor 1   caulerpin   CD24Fc   cefixime   cefpiramide   cefpodoxime   celecoxib   cephalosporin derivatives   cepharanthine   cetirizine   cetylpyridinium chloride   CF101   chebulagic acid   chebulinic acid   chloramphenicol   chlorhexidine   chlorine dioxide   Chlorogenic acid   chlorpheniramine   chlorpromazine   chlorprothixene   chlortalidone   ChloViD2020   chrysin   Chyawanprash   ciclesonide   cidofovir   CIGB-325   ciglitazone   cilazapril   cinnamaldehyde   Cinnamic amides   cinobufagin   ciprofloxacin   cisplatin   Citronellol   Cl-amidine   clazakizumab   clemastine fumarate   clevudine   clodronic-acid   clofazimine   clofibrate   clofoctol   clonazepam   clonidine   clopidogrel   clozapine   CLSP-2   cobicistat   coclaurine   Codivir   colforsin   colistin   concanamycin A   coniferyl aldehyde   conivaptan   copper(II) gluconate   coptisine   cordifoliside   cordycepin   corilagin   cornuside   corticosterone   Cosmosiin   coumarin   coumaroylquinic acids   coumestrol   COVI-AMG/COVI-DROPS   COVI-GUARD   CoViTris2020   CpdD   crambescidin 786   crambescidin 826   crinine   crizanlizumab   crocin   cryptomerin   cryptomisrine   cryptophycin 1   cryptophycin 52   Cryptoquindoline   cryptospirolepine   cryptotanshinone   crytospirolepine   CT-P59   CTB-ACE2 gum   Cucurbitacin G 2-glucoside   cyanidin   cyanidin 3-O-rutinoside   cyanidin 5-O-β-D-glucoside   cyanidin-3-O-glucoside   cyanin   cycloeucalenol   cycloheximide   cyclophosphamide   cyclosporine   cynarin   CYNK-001   cysteamine   cystodion E   cytarabine   cytochalasin Z8   D-α-tocopherol polyethylene glycol succinate   daclatasvir   dactinomycin   daidzein   danoprevir   darolutamide   darunavir   Darunavir Ethanolate   dasatinib   Daturaolone   daunorubicin   deacetylnomilin   decitabine   deguelin   dehydrocostus lactone   dehydrodiisoeugenol   delavirdine   Delphinidin   delphinidin 3-O-rutinoside   demethoxycurcumin   Demethylzeylasteral   demoxytocin   deoxycylindrospermopsin   deoxynortryptoquivaline   deserpidine   desloratadine   dexamethasone   dexanabinol   dexchlorpheniramine   Dfo   diammonium glycyrrhizinate   Diarylheptanoids   diazepam   dichloroacetic-acid   diclofenac   didanosine   Dieckol   dieldrin   diethylstilbestrol   difeterol   Digitoxigenine   digoxin   dihydroartemisinin   dihydroartemisinine   dihydrocelastrol   dihydroergotamine   dihydrokaempferol   dihydromyricetin   Dihydronitidine   dihydroquercetin   Dimethyl Sulfoxide   dimethylnitrosamine   dinaciclib   dinoprost   diosbulbinoside D   diosmin   diphenhydramine   dipyridamole   disulfiram   dithymoquinone   dlunarizine   DMP 777   DNL758   dolastatin   dolutegravir   domperidone   donepezil   doramectin   doxazosin   doxorubicin   doxycycline   duloxetine   ebastine   ebselen   echinacea purpurea   eckol   ecteinascidin   eculizumab   EK1C4   ellagic acid   ellipticine   emetine   emodin   emodine 8-glucosides   emtricitabine   enalapril   engineered ACE2   enoxaparin   entecavir   enterodiol   entinostat   enzalutamide   ephedrine   epicatechin   epigallocatechin   eprinomectin   ergotamine   eriodictyol   erlotinib   erythromycin   estradiol   estragole   estriol   estrogen   estrone   estrone-2,3-quinone   etacrynic acid   etanercept   ethinyl-estradiol   ethoxzolamide   ethyl lauroyl arginine   ethynodiol diacetate   Etodolac   etoposide   etravirine   Euchrenone   euchrestaflavanone A   eugenol   everolimus   evodiamine   Evusheld   examorelin   EXO-CD24   ezetimibe   fangchinoline   faradiol   Farnesiferol B   FBR-002   Febcin   fedratinib   fenofibrate   fenretinide   Ferrocene derivatives   ferulic acid   finasteride   fingolimod   flavanthrin   flecainide   flemiflavanone D   FLOVID-20   fluorescein   fluorouracil   fluoxetine   flutamide   fluvastatin   folic acid   Forsythoside A   Forsythoside I   fostamatinib   fucoidan   fulvestrant   fumonisin-b1   furan   fusicoccin   Galangin   galanthamine   galidesivir   Gallic acid   gallocatechin   Gancao-Banxia   ganciclovir   gardenin A   gastrodin   GB-1   GC-373    GC-376   gefitinib   gemcitabine   genistein   genz-123346   gigantol   giloy   gilteritinib   gimsilumab   ginger   gingerol   ginkgetin   gitoformate   glabridin   glabrone   glafenine   glecaprevir   glucosamine   glutathione   glycine   glycycrrhizin   glycyrrhiza glabra L.   glycyrrhizin   GMC 2-113   GMC 2-29   GR 127935   gramine   grazopavir   grazoprevir   Green Tea   Griffithsin   GRL0617   GW 803430   gycyrrhizin   halichondrin   haloperidol   hanshi zufei   harsingar   hederagenin   heparin   herbacetin   Hesperidin   hinokiflavone   hinokitiol   homo-harringtonine   homoharringtonine   honey   hruceine A   Huashibaidu   hydralazine   hydrochlorothiazide   hydrocortisone   hydrogen peroxide   hydroquinone   hydroxycarbamide   hydroxyurea   hydroxyzine   Hygromycin B   hypericin   hyperin   hypochlorous acid   ibrutinib   ibuprofen   ichangin   IFN-β1a   IFN-β1b   ifosfamide   IFX-1   iguesterin   IKK-2 inhibitor VIII   ilexin B   ilexsaponin B2   imatinib   immunoglobulin   imperialine   indapamide   Indigo   indigo blue   indinavir   indisulam   indole-3-carbinol   Indomethacin   infliximab   INM005   interferon beta-1a   interferon beta-1b   interferon-λ   interleukin-2   ionomycin   ipratropium bromide   irinotecan   Irisolidone   Isatis indigotica root   isoalantolactone   isobavachalcone   isocarboxazide   isocolumbin   Isoferulic acid   isoginkget   isoiguesterin   isoliensinine   isoprinosine   isoquercitrin   isorhamnetin   isorhamnetin-3-O-glucoside   isorientin   isosilybin B   isotretinoin   IT1t dihydrochloride   jakotinib   Jing Si Herbal Tea   Jinhua Qinggan   JMX0286   JMX0301   JMX0941   JQ1   JS016   JT001 (VV116)   JTV519 hemifumarate   Kabasura Kudineer   kaempferol   kaempferol sulphates   kaempferol-3-O-rutinoside   kakkontokasenkyushin'i   Kalmegh   kanamycin   karanjin   keigairengyoto   ketazolam   kinetin   Kobophenol A   kushenol-w   L-arginine   L-glutamine   L-Lysine   laminarin   lanadelumab   lanreotide   Las 51620429   Las 51620435   lauruside   Lectin   ledipasvir   lefamulin   leflunomide   lentinula edodes   lenzilumab   leronlimab   leucal   leucopelargonidin   Levamisole   levetiracetam   levilimab   levofloxacin   Levomefolic   Lianhua Qingwen   licoleafol   liensinine   lignans   Limonene   limonin   linagliptin   liquiritin   lisinopril   lithium-chloride   lomitapide   lonafarnib   loniflavone   loperamide   lopinavir   loratadine   lorazepam   losartan   Lu AE58054   lumacaftor   Lung Cleansing and Detoxifying Decoction   lupeol   lupinifolin   lurasidone   lutein   Luteolin   LY2835219   LY3127804   lycorine   lycorine hydrochloride   lypressin   magnoflorine   magnolol   mallotophilippen D   mangiferin   manidipine   Manuka honey   Maoto   MAPK13-IN-1    maprotiline   masitinib   Maslinic acid   MCOPPB   MDL-28170   Mearnsitrin   medicagol   medicarpin   mefloquine   melitracen   meloxicam   meplazumab   mercaptopurine   MesenCure   metformin glycinate   methapyrilene   methdilazine   methimazole   methotrexate   methotrimeprazine maleate   methoxychlor   Methyl rosmarinates   methylene blue   Methylephedrine   methylnaltrexone   methylochnaflavon   methylprednisolone   metoclopramide   mevalonic acid   MFCD00832476   MFCD02180753   MI-1851   micafungin   mifepristone   milk thistle   miricetine-3-glucoside   mitomycin C   MK-2206   ML414   MLN-3897   momordinic   monolaurin   montelukast   morelloflavone   morin   morusin   moxidectin   moxifloxacin   MPI43   MPI44   MPI46   MPro 13b   MPro N3   MUC1   multimeric soluble ACE2   mycophenolic acid   myricentin   myricetin   myricitrin   myristicin   N-acetylglucosamine   N-methylspiperone   nabiximols   nafamostat   naltrindole isothiocyanate   naphthoquine   naproxen   narciclasine   narcissin   naringen   naringenin   naringin   natamycin   natto extract   neem   negillicine   nelfinavir   Neochlorogenic acid   neomycin   niacinamide   niclosamide   nicotiflorin   nicotinamide mononucleotide   nicotine   nictoflorin   nifedipine   nigricanoside A   nigricanoside B   nilotinib   nimbin   nimesulide   nitisinone   nitrogen   nitroglycerin   nivolumab   nomilin   NOQ19   norepinephrine   norquinadoline A   NSC 33994   nuciferine   nystatin   obacunone   obtivo   ochratoxin-a   okadaic acid   olanzapine   oleanderolide   oleandrin   oleoylethanolamide   oleuropein   omalizumab   ombitasvir   Omega 3   omeprazole   omipalisib   ONO 5334   ononin   opaganib   oridonin   ornipressin   Oroxylin A   orphenadrine   oseltamivir   osimertinib   otosiban   ouabain   oxazepam   oxidopamine   oxygen-ozone immunoceutical therapy   oxytetracycline   ozone therapy   P-57AS3   p-coumaric acid   p-coumaroyltriacetic acid lactone   paclitaxel   pacritinib   palmitoylated ACE2   pamapimod   panduratin A   panobinostat   paritaprevir   paroxetine   PC000361   PC000550   PC000558   PC000573   pectolinarin   pedunculoside   pegylated interferon alpha-2b   peimisine   pemziviptadil   penciclovir   pentachlorophenol   pentamidine   pentosan polysulfate   pentoxifylline   perfenazine   perilla aldehyde   perillyl alcohol   perindopril   periplocoside   petunidin 3,5-Odiglucoside   phenethyl-isothiocyanate    phenformin   phenytoin   phillyrin   phosphodiesterase enzyme type 5 inhibitors   pHOXWELL   phthalocyanine   Phyllaemblinol   phylloflavan   pibrentasvir   piclidenoson   picotamide   pictilisib   pifithrin   pilaralisib   pilocarpine   pioglitazone   piperacetazine   piperaquine   piperine   Piperolactam A   pirfenidone   pirinixic acid   piroxicam   pleurotus ostreatus   plicamycin   podocarpusflavone A   Poly-hydroxyflavones   Poly-methoxyflavones   Polyketide isochaetochromin D1   polymyxin B1   pomegranate   pomegranate peel extract   pomiferin   Porphyridium sp.   pramipexole   Pranayama   pranlukast   pravastatin   prednisolone   prednisone   pristimerin   probenecid   proceragenin A   procyanidin   procynidin B1   progesterone   proglumetacin   proguanil   propadimine   propolis   propolis sulabiroin-A   propranolol   propylthiouracil   protopanaxatriol   Pseudoephedrine   Psiadia punctulata   psoralidin   PTC299   pterostilbene   puerarin   punicalin   Pyramax   pyrazolanthrone   pyrimethamine   pyrimidine   pyronaridine   Q34   quercetagetin   quercetin 3-O-rutinoside   quercetin-3-O-glucuronide   Quinadoline   quinadoline B   quinine   radotinib   ralimetinib   raloxifene   raltegravir   ramelteon   ramipril   ranitidine   rapamycin   ravulizumab   RD-X19   regdanvimab   Rejuveinix   rescimetol   reserpine   resveratrol   rhein   Rheum palmatum   Rhizoma Cibotii   rhodionin   rhoifolin   ribavirin   riboflavin   rifapentine   rimonabant   ritonavir   rivaroxaban   roburicacid   robustaflavone   rosiglitazone   rosoxacin   rosuvastatin   rotenone   rutaecarpine   rutin   ruxolitinib   S-15176 difumarate   S-217622   S1RA   SAB-185   sabizabulin   saffron   saline   salinomycin   Saliravira   Salvianolic acid   salvianolic acid B   saquanivir   saquinavir   saracatinib   saRBD-1   SARS-BLOCK   sarsasapogenin   SB 271046   SB203580   scedapin C   sciadopitysin   scutellarein   scutellaria baicalensis   scutellarin   sea cucumber sulfated polysaccharide   selamectin   selenium   Sepiapterin   Seraph 100 Microbind Affinity filter   serratiopeptidase   sertraline   sesamin   sesaminol   sesamolin   sesamolinol   shallot   shogaol   shosaikotokakikyosekko   Shuang Huang Lian   SI-F019   silibinin   Silmitasertib   silodosin   siltuximab   silybin   silydianin   simeprevir   simvastatin   sinapoyl D glucoside   Sinigrin   sirolimus   sitagliptin   sitosterol   SN00074072   SN00162745   SN00334175   SNG001   sodium bicarbonate   sofosbuvir   solanine   somatotropin   somniferine   sophaline   sorafenib   sotalol   sparfloxacin   Speciophylline   spermidine   spermine   spiperone   spironolactone   Spirulina   stenoparib   STF-62247   strictinin   strychnine   strychnopentamine   stychnopentamine   sulfasalazine   sulindac   sunitinib   suramin   swertianolin   tacrolimus   tadalafil   tafenoquine   tamibarotene   tamoxifen   tamsulosin   tannic acid   tanshinone IIA   tanshinone-I   Tanshinones   taraxerol   taxifolin   tazarotene   TBAJ-876   TCID   TCM5280343   TCM5280445   TCM5280805   TCM5280863   TCM5458190   telmisartan   temazepam   teniposide   Tenofovir   tenofovir alafenamide   tenofovir disoproxil   terbinafine   terflavin A   testosterone   Tetra-O-galloyl-β-d-glucose   tetrachloroethylene   tetracycline   tetrandrine   Tetrodotoxin   thalidomide   thalimonine   thapsigargin   theaflavin   theaflavin-3,3’-digallate   theophylline   thiamazole   thiamine   thioguanine   thioridazine HCl   thiostrepton   thymic peptides   thymoquinone   tideglusib   tiliroside   tingenone   tinocordiside   tinofoviralafenamide   tipifarnib   tipranavir   tiracizine   tirucallin A   TJ003234   tocilizumab   tofacitinib   tofacitinibfedratinib   Tollovir   tolterodine   tomatidine   topotecan   Torchnil   toremifene   torin-2   torososide B   Torreya nucifera   tozumab   TPNT1   Tranilast   tretinoin   triamcinolone   triamterene   tributyltin   trichloroethylene   trichostatin-a   triclosan   trifluomeprazine 2-butenedioate   trifluoperazine 2HCl   trifucol   TriSb92   troglitazone   tunicamycin   tyrphostin-AG-1478   ubiquinone   Uncaric acid   Uncarine F   UNII-O9H5KY11SV   urethane   Urso-deoxycholic acid   ursolic acid   urtica dioica agglutinin   usambarensine   usararotenoid A   valaciclovir   valdecoxib   valproic acid   valsartan   vancomycin   vanillin   VBY-825,   velpatasvir   venlafaxine   verapamil   veratridine   verbascoside   vicenin   vinblastine   vincapusine   vincristine   viomycin   VIR-7831/VIR-7832   virgin coconut oil   vitamin B12   vitamin B9   vitamin E   vitamin K1   vitamin K2   vitexin   vorinostat   VPS34-IN1   VUWCOV059   VUWCOV270   VWCOV267   warfarin   Withanolide A   withanolide B   Withanone   withanoside V   wortmannin   Xanthoangelol E   Xuanfeibaidu   Xuebijing   xylitol   yohimibine   Z LVG CHN2   Z-FA-FMK   Z-gly-leu-phechloromethyl ketone   zabofoxacin   zafirlukast   zanamivir   ZBC260   zearalenone   zidovudine   zinc pyrithione   ZINC000013444414   ZINC000027215482   ZINC000137976768   ZINC000143375720   ZINC000252515584   ZINC000253504766   ZINC000253504770   ZINC02111387   ZINC02122196   ZINC03231196   ZINC04090608   ZINC12006217   ZINC32960814   zingeberene   zingiber officinale   ZINV03977803   ziprasidone   ZnONPs   ZnSeC-Humicin   α-hederin   α-lactalbumin   α-mangostin   β-D-galactose   β-glucan   β-sitosterol   γ-mangostin   δ-viniferin   Δ9-tetrahydrocannabinol   κ-carrageenan   λ-carrageenan  
Kumar et al., Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection, Virology, doi:10.1016/j.virol.2022.05.004
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/abs/pii/S0010482522004577
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.liebertpub.com/doi/10.1089/dna.2022.0312
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/abs/pii/S0010482522004577
Byadi et al., In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2022.2040594
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Abdallah et al., Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics, Plants, doi:10.3390/plants11151914
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Abdallah et al., Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics, Plants, doi:10.3390/plants11151914
Serra et al., Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation, Briefings in Bioinformatics, doi:10.1093/bib/bbab507
https://www.biorxiv.org/content/10.1101/2021.06.04.447066v2
Ma et al., Efficient Neutralization of SARS-CoV-2 Omicron and Other VOCs by a Broad Spectrum Antibody 8G3, bioRxiv, doi:10.1101/2022.02.25.482049
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sim et al., Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition, Cell Reports, doi:10.1016/j.celrep.2022.111117
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Bahadur Gurung et al., An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 Omicron inhibitors, Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2022.103297
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Li et al., Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus, Research Square, doi:10.21203/rs.3.rs-287308/v1
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mahoney et al., Antiviral Activity of Aframomum melegueta Against Severe Acute Respiratory Syndrome Coronaviruses type 1 and 2, South African Journal of Botany, doi:10.1016/j.sajb.2021.12.010
Abdallah et al., Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics, Plants, doi:10.3390/plants11151914
Liu et al., Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2, Viruses, doi:10.3390/v14071588
https://www.mdpi.com/2304-8158/10/9/2084/htm
Elhusseiny et al., In vitro Anti SARS-CoV-2 Activity and Docking Analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms, Infection and Drug Resistance, doi:10.2147/IDR.S362823
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Cecon et al., Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels, bioRxiv, doi:10.1101/2021.12.30.474561
Veerasamy et al., Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach, Journal of Genetic Engineering and Biotechnology, doi:10.1186/s43141-022-00339-y
Veerasamy et al., Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach, Journal of Genetic Engineering and Biotechnology, doi:10.1186/s43141-022-00339-y
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Hicks et al., Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors, Bioorganic & Medicinal Chemistry Letters, doi:10.1016/j.bmcl.2022.128732
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Hicks et al., Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors, Bioorganic & Medicinal Chemistry Letters, doi:10.1016/j.bmcl.2022.128732
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://www.nature.com/articles/s42003-021-02866-9
https://www.nature.com/articles/s41594-020-00536-8
https://www.researchsquare.com/article/rs-121743/v1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063946/
https://www.nature.com/articles/s41392-021-00558-8
https://pubmed.ncbi.nlm.nih.gov/33344913/
https://www.sciencedirect.com/science/article/pii/S092485792030162X
https://www.eurekaselect.com/183729/article
https://link.springer.com/article/10.1007/s43440-021-00231-5
https://link.springer.com/article/10.1007/s40268-021-00351-6
https://www.researchsquare.com/article/rs-493154/v1
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
https://www.mdpi.com/1424-8247/14/3/226
https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(20)30186-5.pdf
https://www.mdpi.com/1424-8247/14/3/226
https://www.mdpi.com/1424-8247/14/3/226
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Alamgir et al., Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records, medRxiv, doi:10.1101/2021.03.22.21254110
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Hicks et al., Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors, Bioorganic & Medicinal Chemistry Letters, doi:10.1016/j.bmcl.2022.128732
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://link.springer.com/article/10.1007/s12640-022-00542-2
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Sa-ngiamsuntorn et al., Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives, Journal of Natural Products, doi:10.1021/acs.jnatprod.0c01324
Wanaratna et al., Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial, medRxiv, doi:10.1101/2021.07.08.21259912
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.pnas.org/content/118/1/e2021450118 (In Vitro)
https://www.physchemres.org/article_149159.html
Liu et al., Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2, Viruses, doi:10.3390/v14071588
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
https://www.mdpi.com/2304-8158/10/9/2084/htm
Adem et al., Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105452
Kumar et al., Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection, Virology, doi:10.1016/j.virol.2022.05.004
Riva et al., A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals, bioRxiv, doi:10.1101/2020.04.16.044016
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
https://pubs.asahq.org/anesthesiology/article-abstract/doi/10.1097/ALN.0000000000003999/11..
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://www.biorxiv.org/content/10.1101/2021.09.10.459744v1.full.pdf (In Vitro)
https://clinicaltrials.gov/ct2/show/NCT04335136
https://www.sciencedirect.com/science/article/abs/pii/S0040595721002043
https://www.sciencedirect.com/science/article/pii/S0953620521003071
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Ivashchenko et al., Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients, Viruses, doi:10.3390/v13071253
Li et al., Hypertonic saline and aprotinin based blockage of SARS-CoV-2 specific furin site cleavage by inhibition of nasal protease activity, bioRxiv, doi:10.1101/2021.11.19.469276
https://onlinelibrary.wiley.com/doi/full/10.1002/iid3.502
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05698-w
https://www.mdpi.com/1999-4915/13/8/1665
https://www.newindianexpress.com/nation/2021/sep/15/clinical-trial-of-anti-viral-drug-umif..
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
https://www.pnas.org/content/118/1/e2021450118 (In Vitro)
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://www.degruyter.com/document/doi/10.1515/jcim-2021-0241/html (In Silico)
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Badraoui et al., Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants, Pharmaceuticals, doi:10.3390/ph15020129
Ahmad et al., Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible Mechanisms, Journal of Exploratory Research in Pharmacology, doi:10.14218/JERP.2021.00034
Tang et al., Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies, doi:10.1186/s12906-022-03523-2
https://www.sciencedirect.com/science/article/abs/pii/S0378874121002439
https://chemrxiv.org/engage/chemrxiv/article-details/60c74a53469df45440f43d21
https://www.openaccessjournals.com/articles/targeting-tgf-pathway-with-covid19-drug-candid..
https://www.biorxiv.org/content/10.1101/2021.09.08.459260v1 (In Vitro)
https://www.biorxiv.org/content/10.1101/2020.04.13.039917v3 (In Vitro)
https://linkinghub.elsevier.com/retrieve/pii/S0378874121002439
https://pubmed.ncbi.nlm.nih.gov/34306988/
https://clinicaltrials.gov/ct2/show/NCT04530617
Gurung et al., Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure, Journal of King Saud University - Science, doi:10.1016/j.jksus.2021.101810
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Abu-Melha et al., Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study, Molecules, doi:10.3390/molecules27020488
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.sciencedirect.com/science/article/pii/S0965229921001096
https://osf.io/s3v6k/
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Jose et al., Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structure and molecular insights, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.132369
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Chaves et al., Atazanavir is a competitive inhibitor of SARS-CoV-2 Mpro, impairing variants replication in vitro and in vivo, bioRxiv, doi:10.1101/2021.11.24.469775
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
https://www.sciencedirect.com/science/article/pii/S2352906721001639
https://onlinelibrary.wiley.com/doi/10.1111/ijcp.14434 (Retrospective Study)
https://www.mdpi.com/1999-4915/13/10/2084
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
https://pubs.acs.org/doi/abs/10.1021/acsinfecdis.1c00278 (In Vitro)
https://www.medrxiv.org/content/10.1101/2022.05.24.22275411v1
Pasla et al., In silico Drug Repurposing for the Identification of Antimalarial Drugs as Candidate Inhibitors of SARS-CoV-2, Anti-Infective Agents, doi:10.2174/2211352519666211202141143
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Mukherjee et al., Anticipated pharmacological role of Aviptadil on COVID-19, Environmental Science and Pollution Research, doi:10.1007/s11356-021-17824-5
Sankhe et al., A Randomized, Controlled, Blinded, Parallel Group, Clinical Trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India., Complementary Therapies in Medicine, doi:10.1016/j.ctim.2022.102824
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.astrazeneca.com/media-centre/press-releases/2021/azd7442-prophylaxis-trial-met..
https://trialsitenews.com/astrazeneca-files-request-for-emergency-use-authorization-for-lo..
https://www.sciencedirect.com/science/article/pii/S2590257122000062
https://www.biorxiv.org/content/10.1101/2020.09.15.296228v1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144927/
https://pubmed.ncbi.nlm.nih.gov/34052578/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ (Retrospective Study)
https://www.researchsquare.com/article/rs-864566/v1
Hinks et al., Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial, The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00263-0
Butler et al., Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial, The Lancet, doi:10.1016/S0140-6736(21)00461-X
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.trialsitenews.com/a/new-oral-drug-for-covid-19first-indigenous-chinese-drug-ap..
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Serra et al., Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation, Briefings in Bioinformatics, doi:10.1093/bib/bbab507
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.mdpi.com/1424-8247/14/9/892
https://www.karger.com/Article/Abstract/519564
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://www.mdpi.com/2304-8158/10/9/2084/htm
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Kar et al., Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2022.108192
https://www.sciencedirect.com/science/article/abs/pii/S2213260021003313
Bronte et al., Baricitinib restrains the immune dysregulation in patients with severe COVID-19, Journal of Clinical Investigation, doi:10.1172/JCI141772
Stebbing et al., JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality, Science Advances, doi:10.1126/sciadv.abe4724
Goletti et al., Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled, New England Journal of Medicine, doi:10.1056/NEJMe2034982
Melikhov et al., Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals, Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2021-220049
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Pasquero et al., Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2, Antiviral Research, doi:10.1016/j.antiviral.2022.105278
Al Khoury et al., In silico evidence of beauvericin antiviral activity against SARS-CoV-2, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.105171
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://link.springer.com/article/10.1007/s12640-022-00542-2
https://www.mdpi.com/2304-8158/10/9/2084/htm
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Kumar et al., Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection, Virology, doi:10.1016/j.virol.2022.05.004
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Zhou et al., Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters, Antiviral Research, doi:10.1016/j.antiviral.2022.105365
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.physchemres.org/article_149159.html
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Taha et al., Identification of FDA-approved Bifonazole as SARS-CoV-2 blocking agent following a bioreporter drug screen, Molecular Therapy, doi:10.1016/j.ymthe.2022.04.025
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Said et al., Synthesis and Greener Pastures Biological Study of Bis-thiadiazoles as Potential Covid-19 Drug Candidates, Arabian Journal of Chemistry, doi:10.1016/j.arabjc.2022.104101
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Beth Yacyshyn et al., Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy, Current Therapeutic Research, doi:10.1016/j.curtheres.2022.100667
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Kocher et al., Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia, bioRxiv, doi:10.1101/2022.01.25.477616
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://arxiv.org/abs/2201.08176
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Akbari et al., Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial, Journal of Trace Elements in Medicine and Biology, doi:10.1016/j.jtemb.2022.126945
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Gomaa et al., Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly, Inflammopharmacology, doi:10.1007/s10787-021-00841-8
Gomaa et al., Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial, Inflammopharmacology, doi:10.1007/s10787-022-00939-7
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0253489
Kader et al., Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study, BMC Sports Science, Medicine and Rehabilitation, doi:10.1186/s13102-022-00451-z
Demarest et al., Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19, bioRxiv, doi:10.1101/2022.03.30.486499
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://trialsitenews.com/brii-bio-initiates-submission-of-emergency-use-authorization-fil..
https://www.sciencedirect.com/science/article/pii/S2590257122000062
https://www.sciencedirect.com/science/article/pii/S2589936820300463?via%3Dihub
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Al-Sehemi et al., In Silico Exploration of Binding Potentials of Anti SARS-CoV-1 Phytochemicals against Main Protease of SARS-CoV-2, Journal of Saudi Chemical Society, doi:10.1016/j.jscs.2022.101453
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://clinicaltrials.gov/ct2/show/NCT04504734
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S2590257122000062
https://www.nature.com/articles/s41598-021-97268-6
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Le-Trilling et al., Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells, bioRxiv, doi:10.1101/2020.11.18.388710
https://www.sciencedirect.com/science/article/pii/S2213422021000688
https://www.mdpi.com/2304-8158/10/9/2084/htm
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://www.biorxiv.org/content/10.1101/2021.08.05.455262v1
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Leka et al., In vitro antiviral activity against SARS‐CoV ‐2 of common herbal medicinal extracts and their bioactive compounds, Phytotherapy Research, doi:10.1002/ptr.7463
https://arxiv.org/abs/2108.13764ANIMAL:https://journals.asm.org/doi/full/10.1128/mBio.0097.. (In Silico)
https://www.sciencedirect.com/science/article/pii/S2352396421000487 (In Vitro)
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00048-7/fulltext
https://www.europeanpharmaceuticalreview.com/news/159375/camostat-cuts-recovery-time-in-ha..
https://clinicaltrials.gov/ct2/show/NCT04530617
Wu et al., Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs, Biomaterials, doi:10.1016/j.biomaterials.2022.121509
https://www.medrxiv.org/content/10.1101/2020.12.10.20240689v1.full
https://www.medrxiv.org/content/10.1101/2022.01.28.22270035v1.full
https://www.frontiersin.org/articles/10.3389/fphar.2022.870493/full
https://www.medrxiv.org/content/10.1101/2022.03.27.22271988v1.full
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Ao et al., The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis, Journal of Infection, doi:10.1016/j.jinf.2022.03.011
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Lazniewski et al., Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations, Methods, doi:10.1016/j.ymeth.2022.02.004
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286244/pdf/main.pdf
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://www.mdpi.com/1424-8247/14/3/226
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
BHARDWAJ et al., Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex, Turkish Journal of Pharmaceutical Sciences, doi:10.4274/tjps.galenos.2021.56957
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
https://www.mdpi.com/2304-8158/10/9/2084/htm
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Welker et al., Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study, The Lancet Infectious Diseases, doi:10.1016/S1473-3099(22)00058-5
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Kumar et al., Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection, Virology, doi:10.1016/j.virol.2022.05.004
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://www.sciencedirect.com/science/article/pii/S2213422021000688
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ (Retrospective Study)
https://www.nature.com/articles/s41392-021-00689-y (Retrospective Study)
https://www.sciencedirect.com/science/article/abs/pii/S1094553921000018 (Retrospective Study)
https://www.biorxiv.org/content/10.1101/2020.10.28.359257v1 (In Vitro)
https://www.sciencedirect.com/science/article/pii/S0929664621004691 (Review)
Anderson et al., Virucidal activity of CPC-containing oral rinses against SARS-CoV-2 variants and are active in the presence of human saliva, bioRxiv, doi:10.1101/2021.08.05.455040
Okamoto et al., Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2, bioRxiv, doi:10.1101/2022.01.27.477964
Okamoto et al., Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, doi:10.1016/j.ajoms.2022.04.001
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Rudrapal et al., Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations, Journal of King Saud University - Science, doi:10.1016/j.jksus.2022.101826
Rudrapal et al., Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations, Journal of King Saud University - Science, doi:10.1016/j.jksus.2022.101826
Mortezaei et al., Variations of SARS-CoV-2 in the Iranian Population and Candidate Putative Drug-like Compounds to Inhibit the Mutated Proteins, Heliyon, doi:10.1016/j.heliyon.2022.e09910
Huang et al., Use of chlorhexidine to eradicate oropharyngeal SARS‐CoV‐2 in COVID‐19 patients, Journal of Medical Virology, doi:10.1002/jmv.26954
https://www.sciencedirect.com/science/article/pii/S0929664621004691 (Review)
Alonso et al., A Retrospective Observational Study of Chlorine Dioxide Effectiveness to Covid19-like Symptoms Prophylaxis in Relatives Living with COVID19 Patients, International Journal of Multidisciplinary Research and Analysis, doi:10.47191/ijmra/v4-i8-02
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
Black, S., Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19, Cureus, doi:10.7759/cureus.20980
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://link.springer.com/article/10.1007/s12640-022-00542-2
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8291116/
https://www.medrxiv.org/content/10.1101/2021.09.07.21261811v1
Song et al., Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial, Journal of Clinical Medicine, doi:10.3390/jcm10163545
Clemency et al., Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19, JAMA Internal Medicine, doi:10.1001/jamainternmed.2021.6759
Mortezaei et al., Variations of SARS-CoV-2 in the Iranian Population and Candidate Putative Drug-like Compounds to Inhibit the Mutated Proteins, Heliyon, doi:10.1016/j.heliyon.2022.e09910
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://link.springer.com/article/10.1007/s12640-022-00542-2
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Pasquero et al., Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2, Antiviral Research, doi:10.1016/j.antiviral.2022.105278
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Song et al., Oral antiviral clevudine compared with placebo in Korean COVID-19 patients with moderate severity, medRxiv, doi:10.1101/2021.12.09.21267566
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Belouzard et al., Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice, bioRxiv, doi:10.1101/2021.06.30.450483
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
You et al., Structural characterization and SARS-CoV-2 inhibitory activity of a sulfated polysaccharide from Caulerpa lentillifera, Carbohydrate Polymers, doi:10.1016/j.carbpol.2021.119006
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.jpost.com/health-and-wellness/israeli-scientists-say-their-antiviral-drug-coul..
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
https://www.biorxiv.org/content/10.1101/2021.09.17.460613v1
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Rudrapal et al., Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations, Journal of King Saud University - Science, doi:10.1016/j.jksus.2022.101826
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Jose et al., Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structure and molecular insights, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.132369
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S2590257122000062
https://www.sciencedirect.com/science/article/pii/S2590257122000062
https://link.springer.com/article/10.1007/s12640-022-00542-2
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Mujwar et al., In silico evaluation of food‐derived carotenoids against SARS‐CoV ‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID ‐19, Journal of Food Biochemistry, doi:10.1111/jfbc.14219
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://link.springer.com/article/10.1007/s12640-022-00542-2
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://www.mdpi.com/2304-8158/10/9/2084/htm
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
https://www.clinicaltherapeutics.com/article/S0149-2918(21)00308-8/fulltext
https://www.sciencedirect.com/science/article/pii/S0006291X21009311
https://www.sciencedirect.com/science/article/pii/S0006291X21013176
https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(21)005..
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Bhowmick et al., Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2021.108113
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s12640-022-00542-2
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Thoene et al., In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants, bioRxiv, doi:10.1101/2021.10.02.462862
Byadi et al., In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2022.2040594
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Pacl et al., Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase, bioRxiv, doi:10.1101/2021.07.13.449251
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Mosharaf et al., Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing, Scientific Reports, doi:10.1038/s41598-022-08073-8
Wang et al., Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture, Communications Biology, doi:10.1038/s42003-022-03101-9
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.mdpi.com/2304-8158/10/9/2084/htm
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.pnas.org/content/118/1/e2021450118 (In Vitro)
https://link.springer.com/article/10.1007/s12640-022-00542-2
https://www.physchemres.org/article_149159.html
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://www.sciencedirect.com/science/article/pii/S2772417421000133
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Bahadur Gurung et al., An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 Omicron inhibitors, Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2022.103297
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sagulkoo et al., Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing, Biomolecules, doi:10.3390/biom12050690
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://con.antppublishing.com/index.php/ittpcovid19/article/view/183
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s12640-022-00542-2
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889471/ (In Vitro)
https://www.mdpi.com/1424-8247/14/3/226
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://www.sciencedirect.com/science/article/abs/pii/S1094553921000018 (Retrospective Study)
Shahanshah et al., In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein, Physics and Chemistry of the Earth, Parts A/B/C, doi:10.1016/j.pce.2022.103188
https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab184/6329274
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Al-Sehemi et al., In Silico Exploration of Binding Potentials of Anti SARS-CoV-1 Phytochemicals against Main Protease of SARS-CoV-2, Journal of Saudi Chemical Society, doi:10.1016/j.jscs.2022.101453
https://www.mdpi.com/2304-8158/10/9/2084/htm
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Cho et al., Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19, Scientific Reports, doi:10.1038/s41598-020-72879-7
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
https://pubmed.ncbi.nlm.nih.gov/32473509/
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Bhowmick et al., Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2021.108113
Adem et al., Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105452
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ (Retrospective Study)
Ostrov et al., Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells, Pathogens, doi:10.3390/pathogens10111514
Demarest et al., Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19, bioRxiv, doi:10.1101/2022.03.30.486499
https://www.biorxiv.org/content/10.1101/2021.09.17.460613v1
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S1319562X21007968
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://con.antppublishing.com/index.php/ittpcovid19/article/view/183
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://www.biorxiv.org/content/10.1101/2021.04.08.439071v1
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Rose et al., The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19, Frontiers in Medicine, doi:10.3389/fmed.2021.637647
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Dhar et al., Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU), medRxiv, doi:10.1101/2022.01.30.22269685
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Kolev et al., Echinacea purpurea for the Long-term Prevention of Viral Respiratory Tract Infections during COVID-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study, medRxiv, doi:10.1101/2021.12.10.21267582
Khorshiddoust et al., Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.112729
Arunkumar et al., Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1921032
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Xia et al., Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Research, doi:10.1038/s41422-020-0305-x
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.sciencedirect.com/science/article/pii/S0308814621026005
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Jang et al., Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2024302118
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Ikemura et al., Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant, bioRxiv, doi:10.1101/2021.12.22.473804
https://pubs.asahq.org/anesthesiology/article-abstract/doi/10.1097/ALN.0000000000003999/11..
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.pnas.org/content/118/1/e2021450118ANIMAL:https://www.nature.com/articles/s4146.. (In Vitro)
https://www.physchemres.org/article_149159.html
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Al-Shuhaib et al., Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.105155
Park et al., Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model, Viruses, doi:10.3390/v13122533
https://link.springer.com/article/10.1007/s12640-022-00542-2
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/1424-8247/14/9/892
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.sciencedirect.com/science/article/pii/S0308814621026005
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Mortezaei et al., Variations of SARS-CoV-2 in the Iranian Population and Candidate Putative Drug-like Compounds to Inhibit the Mutated Proteins, Heliyon, doi:10.1016/j.heliyon.2022.e09910
https://journals.physiology.org/doi/full/10.1152/ajplung.00153.2020
https://www.biorxiv.org/content/10.1101/2021.04.08.439071v1
https://physoc.onlinelibrary.wiley.com/doi/full/10.14814/phy2.14707
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://www.mdpi.com/1424-8247/14/9/892
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sund et al., Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study, BMJ Open, doi:10.1136/bmjopen-2021-053032
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Bhowmick et al., Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2021.108113
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.biorxiv.org/content/10.1101/2021.09.25.461785v1
https://www.researchsquare.com/article/rs-842564/v1 (In Vitro)
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.mdpi.com/1424-8247/14/9/892
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-author..
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.jpost.com/health-science/covid-90-percent-of-patients-treated-with-new-israeli..
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://elifesciences.org/articles/68165
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Luczkowiak et al., Potent Neutralizing Activity of Polyclonal Equine Antibodies against SARS-CoV-2 Variants of Concern, The Journal of Infectious Diseases, doi:10.1093/infdis/jiac331
Munshi et al., An open-labelled, randomised, controlled, proof of concept clinical trial to evaluate the efficacy of AYUSH interventions (Cap.Torchnil + Tab. Febcin) as add-on therapy in the clinical management of moderate Covid-19 patients, Journal of Ayurveda and Integrative Medicine, doi:10.1016/j.jaim.2022.100559
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
https://www.researchsquare.com/article/rs-770724/v1
https://www.frontiersin.org/articles/10.3389/fphar.2021.660490/full
https://www.sciencedirect.com/science/article/pii/S2049080121009249
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Abbas et al., Synthesis and investigation of anti-COVID19 ability of ferrocene Schiff base derivatives by quantum chemical and molecular docking, Journal of Molecular Structure, doi:10.1016/j.molstruc.2021.132242
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.mdpi.com/2304-8158/10/9/2084/htm
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://elifesciences.org/articles/68165
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://flowpharma.com/product/flovid-20/
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1829082
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3896539
https://www.nature.com/articles/s41598-021-85049-0
https://pubmed.ncbi.nlm.nih.gov/32975484/
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.physchemres.org/article_149159.html
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Fu et al., Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses, International Journal of Biological Macromolecules, doi:10.1016/j.ijbiomac.2022.03.145
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/abs/pii/S104620232100205X (In Silico)
https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts...
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://pubs.rsc.org/en/content/articlelanding/2020/fo/d0fo02017f/unauth
https://www.sciencedirect.com/science/article/pii/S2589014X20302450https://www.mdpi.com/16..
https://www.sciencedirect.com/science/article/abs/pii/S0144861721009541
Pradhan et al., A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections, Carbohydrate Polymers, doi:10.1016/j.carbpol.2022.119551
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
https://www.mdpi.com/2304-8158/10/9/2084/htm
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
http://hdl.handle.net/10523/13405
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Luo et al., Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID‐19 by dual binding to IL-6/STAT3, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105457
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Abdallah et al., Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics, Plants, doi:10.3390/plants11151914
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Tsai et al., Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.112802
GC-373   Submit Updates
https://arxiv.org/abs/2201.08176
https://arxiv.org/abs/2201.08176
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sagulkoo et al., Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing, Biomolecules, doi:10.3390/biom12050690
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.mdpi.com/2304-8158/10/9/2084/htm
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Peng et al., Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo, Science China Life Sciences, doi:10.1007/s11427-021-2031-7
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Sharma et al., Nutraceuticals aid in managing COVID-19, World Journal of Pharmaceutical Sciences, doi:10.54037/WJPS.2022.100204
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://pubmed.ncbi.nlm.nih.gov/32463221/
https://pubmed.ncbi.nlm.nih.gov/32992775/
https://pubmed.ncbi.nlm.nih.gov/32708578/
https://pubmed.ncbi.nlm.nih.gov/33336769/
https://pubmed.ncbi.nlm.nih.gov/33117175/
https://pubmed.ncbi.nlm.nih.gov/32322478/
Li, C., Can Glycine Mitigate COVID-19 Associated Tissue Damage and Cytokine Storm?, Radiation Research, doi:10.1667/RADE-20-00146.1
Kumar et al., Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation, Antioxidants, doi:10.3390/antiox11010050
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Bisht et al., Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: potential pharmacological applications with mechanistic insight., Phytomedicine Plus, doi:10.1016/j.phyplu.2021.100206
https://www.mdpi.com/1999-4915/13/4/609/pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227143/
https://pubmed.ncbi.nlm.nih.gov/33918301/
https://www.sciencedirect.com/science/article/pii/S2667031321000257
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04706-3
Khorshiddoust et al., Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.112729
https://www.frontiersin.org/articles/10.3389/fphar.2021.631206/full
https://www.mdpi.com/2223-7747/10/12/2600
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://pubmed.ncbi.nlm.nih.gov/34375189/ (In Vitro)
https://www.mdpi.com/1660-3397/19/8/418
Bhowmick et al., Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105474
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Li et al., Exploration of hanshi zufei prescription for treatment of COVID-19 based on network pharmacology, Chinese Herbal Medicines, doi:10.1016/j.chmed.2021.06.006
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
https://www.sciencedirect.com/science/article/abs/pii/S1386142521011720
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://www.mdpi.com/2072-6643/13/8/2800
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Adem et al., Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105452
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Tao et al., Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol, Journal of Inorganic Biochemistry, doi:10.1016/j.jinorgbio.2022.111777
Ma et al., Homo-harringtonine, highly effective against coronaviruses, is safe in treating COVID-19 by nebulization, Science China Life Sciences, doi:10.1007/s11427-021-2093-2
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.medrxiv.org/content/10.1101/2020.10.30.20217364v4
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://www.sciencedirect.com/science/article/abs/pii/S0944711321004086
Wu et al., Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China, Frontiers in Pharmacology, doi:10.3389/fphar.2020.615287
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Alamgir et al., Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records, medRxiv, doi:10.1101/2021.03.22.21254110
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Burgos-Ramos et al., Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics?, The Saudi Dental Journal, doi:10.1016/j.sdentj.2022.01.005
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308628/
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8289588/
https://www.sciencedirect.com/science/article/pii/S0929664621004691 (Review)
http://www.orthomolecular.org/resources/omns/v17n13.shtml
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Foster et al., The Use of Hydroxyurea in the Treatment of COVID-19, The Journal of Critical Care Medicine, doi:10.2478/jccm-2021-0019
Sagulkoo et al., Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing, Biomolecules, doi:10.3390/biom12050690
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ (Retrospective Study)
Al-Sehemi et al., In Silico Exploration of Binding Potentials of Anti SARS-CoV-1 Phytochemicals against Main Protease of SARS-CoV-2, Journal of Saudi Chemical Society, doi:10.1016/j.jscs.2022.101453
https://link.springer.com/article/10.1007/s12640-022-00542-2
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Shahhamzehei et al., In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library, Pharmaceuticals, doi:10.3390/ph15030308
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Giarratana et al., A sprayable Acid-Oxidizing solution containing hypochlorous acid (AOS2020) efficiently and safely inactivates SARS-Cov-2: a new potential solution for upper respiratory tract hygiene, European Archives of Oto-Rhino-Laryngology, doi:10.1007/s00405-021-06644-5
Takeda et al., Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus, Biochemical and Biophysical Research Communications, doi:10.1016/j.bbrc.2020.07.029
Mueller et al., A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions, Drug Research, doi:10.1055/a-1467-5956
Rasmussen et al., Inhalation of a fog of hypochlorous acid (HOCl): Biochemical, antimicrobial, and pathological assessment, Research Square, doi:10.21203/rs.3.rs-1009101/v1
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Aloufi et al., Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing, Molecules, doi:10.3390/molecules27082401
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://link.springer.com/article/10.1007/s12640-022-00542-2
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.medrxiv.org/content/10.1101/2021.07.24.21261007v2 (RCT)
Pendharkar et al., Analysis of Indomethacin as a potential drug for COVID-19 using CoV-DrugX Pipeline, Center for Open Science, doi:10.31219/osf.io/txmra
Ravichandran et al., An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients, Scientific Reports, doi:10.1038/s41598-022-10370-1
Chakraborty et al., In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105788
Mortezaei et al., Variations of SARS-CoV-2 in the Iranian Population and Candidate Putative Drug-like Compounds to Inhibit the Mutated Proteins, Heliyon, doi:10.1016/j.heliyon.2022.e09910
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Farizano Salazar et al., Safety and effectiveness of RBD-specific polyclonal equine F(ab′)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: a retrospective cohort study., medRxiv, doi:10.1101/2022.04.07.22273558
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://www.biorxiv.org/content/10.1101/2022.01.21.477296v1
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://link.springer.com/article/10.1007/s12640-022-00542-2
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
unknown, u., P5‐145: COVID‐19: Performance of oseltamivir and isoprinosine in neutrophil‐to‐lymphocyte ratio improvement from confirmed COVID‐19 patients in Saiful Anwar General Hospital, Malang, Respirology, doi:10.1111/resp.14150_352
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
Shahhamzehei et al., In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library, Pharmaceuticals, doi:10.3390/ph15030308
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Aloufi et al., Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing, Molecules, doi:10.3390/molecules27082401
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Lu et al., Jing Si Herbal Drink as a Prospective Adjunctive Therapy for COVID-19 Treatment: Molecular evidence and mechanisms, Pharmacological Research - Modern Chinese Medicine, doi:10.1016/j.prmcm.2021.100024
Hsieh et al., Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study, Frontiers in Nutrition, doi:10.3389/fnut.2022.832321
https://www.medrxiv.org/content/10.1101/2022.05.16.22275074v1
Wu et al., Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China, Frontiers in Pharmacology, doi:10.3389/fphar.2020.615287
https://www.sciencedirect.com/science/article/abs/pii/S0166354222001504
https://www.sciencedirect.com/science/article/abs/pii/S0166354222001504
https://www.sciencedirect.com/science/article/abs/pii/S0166354222001504
Qiao et al., Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2021450118
https://trialsitenews.com/chinese-monoclonal-antibody-product-sees-expansion-in-use-worldw..
https://www.trialsitenews.com/p/trialsitenews/novel-chinese-oral-covid-19-treatment-begins..
https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0524/2022052301170.pdf
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://pubmed.ncbi.nlm.nih.gov/34526104/ (RCT)
Jamshidnia et al., An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects, Current Pharmaceutical Design, doi:10.2174/1381612828666220722124826
Liu et al., Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2, Viruses, doi:10.3390/v14071588
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Chaves et al., Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors Than Isoflavone and Flavones, Viruses, doi:10.3390/v14071458
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
https://www.mdpi.com/2304-8158/10/9/2084/htm
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
Ono et al., Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study, Frontiers in Pharmacology, doi:10.3389/fphar.2022.844072
https://de.nachrichten.yahoo.com/thailand-gefaengnis-insassen-stellen-ihr-covid-heilmittel..
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Ono et al., Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study, Frontiers in Pharmacology, doi:10.3389/fphar.2022.844072
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Souza et al., Identification and preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral and anti-inflammatory therapy, Research Square, doi:10.21203/rs.3.rs-1533971/v1
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00405-3/fulltext (RCT)
Izzo et al., Combining L-Arginine with Vitamin C Improves Long-COVID Symptoms: The Nationwide Multicenter LINCOLN Study, Pharmacological Research, doi:10.1016/j.phrs.2022.106360
Cengiz et al., Effect of oral l-Glutamine supplementation on Covid-19 treatment, Clinical Nutrition Experimental, doi:10.1016/j.yclnex.2020.07.003
https://www.mdpi.com/1999-4915/13/7/1301/htm
https://www.researchgate.net/publication/354035681_Theoretical_Discussion_of_the_Probable_..
https://www.researchgate.net/publication/345916326_Amino_Acid_L-Lysine_SARS-CoV-2_COVID-19..
https://www.researchgate.net/publication/344210822_Lysine_Therapy_for_SARS-CoV-2
Arunkumar et al., Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1921032
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Medhat et al., Sofosbuvir/Ledipasvir in Combination or Nitazoxanide Alone are Safe and Efficient Treatments for COVID-19 Infection: A Randomized Controlled Trial for Repurposing antivirals, Arab Journal of Gastroenterology, doi:10.1016/j.ajg.2022.04.005
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Elhusseiny et al., In vitro Anti SARS-CoV-2 Activity and Docking Analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms, Infection and Drug Resistance, doi:10.2147/IDR.S362823
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00494-X/fulltext
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Roostaei Firozabad et al., Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial, BMC Infectious Diseases, doi:10.1186/s12879-021-05983-2
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://link.springer.com/article/10.1007/s00011-021-01507-5 (RCT)
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Xia et al., Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19, Cell Proliferation, doi:10.1111/cpr.12949
Wu et al., Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China, Frontiers in Pharmacology, doi:10.3389/fphar.2020.615287
Jamshidnia et al., An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects, Current Pharmaceutical Design, doi:10.2174/1381612828666220722124826
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S0223523421007066
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sharma et al., Nutraceuticals aid in managing COVID-19, World Journal of Pharmaceutical Sciences, doi:10.54037/WJPS.2022.100204
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://arxiv.org/abs/2201.08176
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889471/ (In Vitro)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ (Retrospective Study)
Oh et al., Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19, Current Issues in Molecular Biology, doi:10.3390/cimb44040109
https://jcmimagescasereports.org/article/JCM-V1-1016.pdf
https://www.sciencedirect.com/science/article/abs/pii/S1094553921000018 (Retrospective Study)
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://link.springer.com/article/10.1007/s12640-022-00542-2
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://link.springer.com/article/10.1007/s12640-022-00542-2
Wu et al., Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China, Frontiers in Pharmacology, doi:10.3389/fphar.2020.615287
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s12640-022-00542-2
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://pubmed.ncbi.nlm.nih.gov/34236507/ (In Silico)
Munafò et al., Quercetin and Luteolin Are Single-digit Micromolar Inhibitors of the SARS-CoV-2 RNA-dependent RNA Polymerase, Research Square, doi:10.21203/rs.3.rs-1149846/v1
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Shahhamzehei et al., In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library, Pharmaceuticals, doi:10.3390/ph15030308
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/abs/pii/S0010482522004577
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
https://qspace.qu.edu.qa/handle/10576/24398
Nabeshima et al., Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study, Journal of Infection and Chemotherapy, doi:10.1016/j.jiac.2022.03.014
MAPK13-IN-1   Submit Updates
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Drayman et al., Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2, Science, doi:10.1126/science.abg5827
Martínez‐Ortega et al., In Silico Characterization of Masitinib Interaction with SARS‐CoV‐2 Main Protease, ChemMedChem, doi:10.1002/cmdc.202100375
Drayman et al., Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro, bioRxiv, doi:10.1101/2020.08.31.274639
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Riva et al., A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals, bioRxiv, doi:10.1101/2020.04.16.044016
https://www.mdpi.com/2304-8158/10/9/2084/htm
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Pasla et al., In silico Drug Repurposing for the Identification of Antimalarial Drugs as Candidate Inhibitors of SARS-CoV-2, Anti-Infective Agents, doi:10.2174/2211352519666211202141143
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.jpost.com/health-and-wellness/coronavirus/israeli-drug-for-severe-covid-reduce..
Ventura-López et al., Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113223
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.frontiersin.org/articles/10.3389/fphar.2020.600372/full
https://www.sciencedirect.com/science/article/pii/S0753332221008064
https://pubmed.ncbi.nlm.nih.gov/34019535/
Cagno et al., Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro, Scientific Reports, doi:10.1038/s41598-021-92481-9
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Pászti-Gere et al., In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113124
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Aloufi et al., Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing, Molecules, doi:10.3390/molecules27082401
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sagulkoo et al., Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing, Biomolecules, doi:10.3390/biom12050690
Gassen et al., SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals, Nature Communications, doi:10.1038/s41467-021-24007-w
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Riva et al., A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals, bioRxiv, doi:10.1101/2020.04.16.044016
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Barberis et al., Understanding protection from SARS-CoV-2 using metabolomics, Scientific Reports, doi:10.1038/s41598-021-93260-2
Angeles-Agdeppa et al., Virgin coconut oil is effective in lowering C-reactive protein levels among suspect and probable cases of COVID-19, Journal of Functional Foods, doi:10.1016/j.jff.2021.104557
https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/..
Preuss et al., Suggestions for Combatting COVID-19 by Natural Means in the Absence of Standard Medical Regimens, Journal of the American College of Nutrition, doi:10.1080/07315724.2020.1779554
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Luedemann et al., Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing, Computational and Structural Biotechnology Journal, doi:10.1016/j.csbj.2022.01.024
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Alugubelli et al., A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals, European Journal of Medicinal Chemistry, doi:10.1016/j.ejmech.2022.114596
Alugubelli et al., A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals, European Journal of Medicinal Chemistry, doi:10.1016/j.ejmech.2022.114596
Alugubelli et al., A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals, European Journal of Medicinal Chemistry, doi:10.1016/j.ejmech.2022.114596
https://arxiv.org/abs/2201.08176
https://arxiv.org/abs/2201.08176
https://www.biorxiv.org/content/10.1101/2021.10.29.466402v1
Kayabolen et al., Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection in vitro and in vivo, bioRxiv, doi:10.1101/2021.01.04.425128
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Chaves et al., Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors Than Isoflavone and Flavones, Viruses, doi:10.3390/v14071458
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
https://www.mdpi.com/1424-8247/14/9/892
https://www.mdpi.com/2304-8158/10/9/2084/htm
Jamshidnia et al., An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects, Current Pharmaceutical Design, doi:10.2174/1381612828666220722124826
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S2049080121005240
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
https://www.mdpi.com/1999-4915/13/9/1768 (In Vitro)
https://journals.asm.org/doi/full/10.1128/mBio.00970-21 (Animal Study)
https://www.biorxiv.org/content/10.1101/2021.07.08.451654v1 (Animal Study)
https://www.sciencedirect.com/science/article/pii/S2589537021004491 (RCT)
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Song et al., Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro, Molecules, doi:10.3390/molecules27030712
https://www.mdpi.com/1420-3049/26/9/2593/htm
Asadi et al., Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, doi:10.1016/j.dsx.2021.102319
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.mdpi.com/2304-8158/10/9/2084/htm
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
https://www.sciencedirect.com/science/article/pii/S0006291X21010718
https://pubmed.ncbi.nlm.nih.gov/33891569/ (RCT)
Eze et al., Anti-COVID-19 Potential of Azadirachta indica (Neem) Leaf Extract, Scientific African, doi:10.1016/j.sciaf.2022.e01184
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
https://www.sciencedirect.com/science/article/pii/S1319562X21007968
https://www.sciencedirect.com/science/article/pii/S0166354222000808
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://kidney360.asnjournals.org/content/2/1/33?WT.MC_ID=TMD01&utm_campaign=Kidney360_Tre..
https://www.sciencedirect.com/science/article/pii/S2049080121007299doi:10.1111/bph.15843
Jitobaom et al., Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations, BMC Pharmacology and Toxicology, doi:10.1186/s40360-022-00580-8
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Gassen et al., SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals, Nature Communications, doi:10.1038/s41467-021-24007-w
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.egaceutical.com/wp-content/uploads/2021/12/rapid-clinical-improvement-in-ill-c..
https://pubmed.ncbi.nlm.nih.gov/32790936/
https://clinicaltrials.gov/ct2/show/NCT04583410
Lewnard et al., Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California, medRxiv, doi:10.1101/2022.01.11.22269045
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Kanchibhotla et al., Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS CoV-2 disease: A Single-arm trial, Research Square, doi:10.21203/rs.3.rs-923003/v4
Bhardwaja et al., An integrative approach to clinical recovery for COVID-19 patients using an Ayurvedic formulation: A multicentric double-blind randomized control trial., Research Square, doi:10.21203/rs.3.rs-1165680/v1
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Kar et al., Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2022.108192
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Akbari et al., Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial, Journal of Trace Elements in Medicine and Biology, doi:10.1016/j.jtemb.2022.126945
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.mdpi.com/2304-8158/10/9/2084/htm
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Wang et al., Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture, Communications Biology, doi:10.1038/s42003-022-03101-9
https://www.sciencedirect.com/science/article/abs/pii/S0952327821000132
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-02795-5
https://www.authorea.com/doi/full/10.22541/au.161051252.26168891
https://www.sciencedirect.com/science/article/pii/S2589004221010087
https://www.plefa.com/article/S0952-3278(21)00013-2/fulltext
https://www.nature.com/articles/s41598-021-91794-z
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Jang et al., Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2024302118
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Riva et al., A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals, bioRxiv, doi:10.1101/2020.04.16.044016
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Winthrop et al., Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac232
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Zendehdel et al., Efficacy of oseltamivir in the treatment of patients infected with Covid-19, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.103679
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Cho et al., Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19, Scientific Reports, doi:10.1038/s41598-020-72879-7
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Franzini et al., Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported, International Immunopharmacology, doi:10.1016/j.intimp.2020.106879
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Hernández et al., Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study, International Immunopharmacology, doi:10.1016/j.intimp.2020.107261
Shah et al., Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study), International Immunopharmacology, doi:10.1016/j.intimp.2020.107301
Tascini et al., Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience, Internal and Emergency Medicine, doi:10.1007/s11739-020-02542-6
Araimo et al., Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial, Journal of Medical Virology, doi:10.1002/jmv.26636
Fernández-Cuadros et al., Compassionate Use of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: a Case-Control Study, SN Comprehensive Clinical Medicine, doi:10.1007/s42399-021-00849-9
https://jppres.com/jppres/ozone-in-covid-19/
Sozio et al., CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial, International Immunopharmacology, doi:10.1016/j.intimp.2021.107874
Fernández-Cuadros et al., Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results, SN Comprehensive Clinical Medicine, doi:10.1007/s42399-020-00374-1
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Bhowmick et al., Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2021.108113
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://onlinelibrary.wiley.com/doi/full/10.1002/adma.202103471
Setz et al., Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern, International Journal of Molecular Sciences, doi:10.3390/ijms23126830
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009840
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286244/pdf/main.pdf
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Bhowmick et al., Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105474
Bhowmick et al., Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105474
Bhowmick et al., Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105474
Bhowmick et al., Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105474
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S1201971221006779 (RCT)
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Bertini et al., Pentosan polysulfate inhibits attachment and infection by SARS-CoV-2 in vitro: insights into structural requirements for binding., bioRxiv, doi:10.1101/2021.12.19.473359
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://link.springer.com/article/10.1007/s12640-022-00542-2
Le-Trilling et al., Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells, bioRxiv, doi:10.1101/2020.11.18.388710
Le-Trilling et al., Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells, bioRxiv, doi:10.1101/2020.11.18.388710
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
phenethyl-isothiocyanate   Submit Updates
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://link.springer.com/article/10.1007/s12640-022-00542-2
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7883493/
https://pubmed.ncbi.nlm.nih.gov/32526061/
Balmforth et al., Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial., Journal of Clinical Virology, doi:10.1016/j.jcv.2022.105248
https://www.nature.com/articles/s41598-021-99013-5 (RCT)
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Aloufi et al., Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing, Molecules, doi:10.3390/molecules27082401
Wang et al., Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture, Communications Biology, doi:10.1038/s42003-022-03101-9
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://link.springer.com/article/10.1007/s12640-022-00542-2
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://link.springer.com/article/10.1007/s12640-022-00542-2
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Setz et al., Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern, International Journal of Molecular Sciences, doi:10.3390/ijms23126830
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Artigas et al., In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm, PLOS ONE, doi:10.1371/journal.pone.0240149
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
dos Reis et al., Effects of bioactive compounds from Pleurotus mushrooms on COVID-19 risk factors associated with the cardiovascular system, Journal of Integrative Medicine, doi:10.1016/j.joim.2022.07.002
Elhusseiny et al., In vitro Anti SARS-CoV-2 Activity and Docking Analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms, Infection and Drug Resistance, doi:10.2147/IDR.S362823
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S2590257121000523 (In Silico)
https://www.sciencedirect.com/science/article/pii/S2590257121000523 (In Silico)
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s11010-020-03981-7
https://psmpublishers.org/issues/the-use-of-fresh-pomegranate-juice-in-the-treatment-of-co..
https://www.sciencedirect.com/science/article/pii/S0045206821005228
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Hlima et al., In silico evidence of antiviral activity against SARS-CoV-2 main protease of oligosaccharides from Porphyridium sp., Science of The Total Environment, doi:10.1016/j.scitotenv.2022.155580
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sarwal et al., Efficacy of Pranayama in Preventing COVID-19 in Exposed Healthcare Professionals: A Quasi-Randomized Clinical Trial, Journal of Ayurveda and Integrative Medicine, doi:10.1016/j.jaim.2022.100586
Lazniewski et al., Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations, Methods, doi:10.1016/j.ymeth.2022.02.004
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.nature.com/articles/s41598-021-97658-w (Animal Study)
Kar et al., Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study, Journal of Molecular Graphics and Modelling, doi:10.1016/j.jmgm.2022.108192
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://link.springer.com/article/10.1007/s12640-022-00542-2
https://www.medrxiv.org/content/10.1101/2021.01.08.20248932v1
https://www.scienceopen.com/hosted-document?doi=10.14293/S2199-1006.1.SOR-.PPZR1OD.v1
Silveira et al., Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2021.111526
https://jtim.tums.ac.ir/index.php/jtim/article/view/408
Bilir et al., Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals, ScienceOpen, doi:10.14293/S2199-1006.1.SOR-.PPZR1OD.v1
https://www.sciencedirect.com/science/article/pii/S1018364721003694
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Abdallah et al., Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics, Plants, doi:10.3390/plants11151914
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://www.koreabiomed.com/news/articleView.html?idxno=11556
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Schultz et al., Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2, Nature, doi:10.1038/s41586-022-04482-x
https://www.biorxiv.org/content/10.1101/2021.09.30.462449v1
Cui et al., Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection, iScience, doi:10.1016/j.isci.2021.103684
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
https://www.mdpi.com/2304-8158/10/9/2084/htm
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Große et al., Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2, Viruses, doi:10.3390/v13040647
Mosharaf et al., Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing, Scientific Reports, doi:10.1038/s41598-022-08073-8
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Nicastri et al., A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19, eClinicalMedicine, doi:10.1016/j.eclinm.2022.101450
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Cecon et al., Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels, bioRxiv, doi:10.1101/2021.12.30.474561
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mosharaf et al., Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing, Scientific Reports, doi:10.1038/s41598-022-08073-8
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.medrxiv.org/content/10.1101/2021.10.17.21265058v1
https://pubmed.ncbi.nlm.nih.gov/34724174/
Streinu-Cercel et al., Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients with Mild-to-Moderate Coronavirus Disease 2019, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac053
Lee et al., Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score–matched retrospective cohort study, International Immunopharmacology, doi:10.1016/j.intimp.2022.108570
Uckun et al., Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19, medRxiv, doi:10.1101/2022.02.12.22270748
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://www.medrxiv.org/content/10.1101/2020.07.21.20151423v1 (Retrospective Study)
https://www.mdpi.com/2076-3921/10/9/1440
https://www.tandfonline.com/doi/full/10.1080/21623945.2021.1965315
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Mortezaei et al., Variations of SARS-CoV-2 in the Iranian Population and Candidate Putative Drug-like Compounds to Inhibit the Mutated Proteins, Heliyon, doi:10.1016/j.heliyon.2022.e09910
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.sciencedirect.com/science/article/pii/S0308814621026005
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Khorshiddoust et al., Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.112729
https://www.sciencedirect.com/science/article/pii/S2213422021000688
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Belhassan et al., In silico detection of potential inhibitors from vitamins and their derivatives compounds against SARS-CoV-2 main protease by using molecular docking, molecular dynamic simulation and ADMET profiling, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.132652
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://link.springer.com/article/10.1007/s12640-022-00542-2
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://arxiv.org/abs/2201.08176
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Gaitán-Duarte et al., Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19, medRxiv, doi:10.1101/2021.07.06.21260085
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://elifesciences.org/articles/68165
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Srus et al., In Silico study of Wheatgrass constituents against Coronavirus COVID-19 Proteins., Research Square, doi:10.21203/rs.3.rs-1167417/v1
https://link.springer.com/article/10.1007/s12640-022-00542-2
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Zhu et al., Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
Adem et al., Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105452
HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.mdpi.com/1424-8247/14/9/892
https://www.mdpi.com/2304-8158/10/9/2084/htm
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Sasaki et al., Oral administration of S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and accelerates recovery from clinical aspects of COVID-19, bioRxiv, doi:10.1101/2022.02.14.480338
https://www.thepharmaletter.com/article/shionogi-progressing-covid-19-oral-antiviral-agent..
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
https://www.sciencedirect.com/science/article/pii/S2590257122000062
https://www.trialsitenews.com/p/trialsitenews/safety-monitoring-board-stops-clinical-trial..
Mujwar et al., In silico evaluation of food‐derived carotenoids against SARS‐CoV ‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID ‐19, Journal of Food Biochemistry, doi:10.1111/jfbc.14219
Kimura et al., Interim analysis of an open‐label randomized controlled trial evaluating nasal irrigations in non‐hospitalized patients with coronavirus disease 2019, International Forum of Allergy & Rhinology, doi:10.1002/alr.22703
https://pubmed.ncbi.nlm.nih.gov/33772626/ (Review)
Li et al., Hypertonic saline and aprotinin based blockage of SARS-CoV-2 specific furin site cleavage by inhibition of nasal protease activity, bioRxiv, doi:10.1101/2021.11.19.469276
Peng et al., Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo, Science China Life Sciences, doi:10.1007/s11427-021-2031-7
Khorshiddoust et al., Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.112729
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Lazniewski et al., Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations, Methods, doi:10.1016/j.ymeth.2022.02.004
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Weinstein et al., A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants, iScience, doi:10.1016/j.isci.2022.103960
Watson et al., Peptide Antidotes to SARS-CoV-2 (COVID-19), bioRxiv, doi:10.1101/2020.08.06.238915
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
https://link.springer.com/article/10.1007/s12640-022-00542-2
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://www.mdpi.com/2304-8158/10/9/2084/htm
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://pubs.rsc.org/en/content/articlelanding/2020/fo/d0fo02017f/unauth
https://www.biorxiv.org/content/10.1101/2021.04.08.439071v1
Aminpour et al., In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds, Computation, doi:10.3390/computation10040051
https://pubmed.ncbi.nlm.nih.gov/32992282
https://www.sciencedirect.com/science/article/pii/S030698772031104X
https://www.sciencedirect.com/science/article/pii/S2405457721011074
https://www.mdpi.com/2072-6643/11/9/2101
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Schmidt et al., Interim-analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry, Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfab347
Sharma et al., Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19, Frontiers in Pharmacology, doi:10.3389/fphar.2021.603997
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Peng et al., Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo, Science China Life Sciences, doi:10.1007/s11427-021-2031-7
https://www.mdpi.com/1424-8247/14/3/226
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://iopscience.iop.org/article/10.1088/1755-1315/995/1/012024/meta
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Ono et al., Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study, Frontiers in Pharmacology, doi:10.3389/fphar.2022.844072
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Tsai et al., ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern, Antiviral Research, doi:10.1016/j.antiviral.2022.105271
Bosch-Barrera et al., Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients, Journal of Clinical Medicine, doi:10.3390/jcm9061770
https://www.senhwabio.com/en/news/20211020
https://trialsitenews.com/senhwa-presents-positive-data-from-phase-2-trial-of-silmitaserti..
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Jamshidnia et al., An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects, Current Pharmaceutical Design, doi:10.2174/1381612828666220722124826
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Lazniewski et al., Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations, Methods, doi:10.1016/j.ymeth.2022.02.004
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Jose et al., Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structure and molecular insights, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.132369
Al-Sehemi et al., In Silico Exploration of Binding Potentials of Anti SARS-CoV-1 Phytochemicals against Main Protease of SARS-CoV-2, Journal of Saudi Chemical Society, doi:10.1016/j.jscs.2022.101453
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://www.medrxiv.org/content/10.1101/2022.01.21.22269322v1
Srivastava et al., The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach, Journal of the Indian Chemical Society, doi:10.1016/j.jics.2022.100640
Power et al., Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein, Bioorganic Chemistry, doi:10.1016/j.bioorg.2021.105574
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Monk et al., Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial, The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(20)30511-7
https://oaltoacre.com/pesquisa-do-acre-tem-resultado-positivo-no-uso-do-bicarbonato-contra..
Hsu et al., The effect of sofosbuvir-based treatment on the clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials, International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2022.106545
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Medhat et al., Sofosbuvir/Ledipasvir in Combination or Nitazoxanide Alone are Safe and Efficient Treatments for COVID-19 Infection: A Randomized Controlled Trial for Repurposing antivirals, Arab Journal of Gastroenterology, doi:10.1016/j.ajg.2022.04.005
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Gassen et al., SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals, Nature Communications, doi:10.1038/s41467-021-24007-w
Gassen et al., SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals, Nature Communications, doi:10.1038/s41467-021-24007-w
Bahadur Gurung et al., An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 Omicron inhibitors, Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2022.103297
https://link.springer.com/article/10.1007/s12640-022-00542-2
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://www.medrxiv.org/content/10.1101/2022.01.21.22269322v1
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://pubmed.ncbi.nlm.nih.gov/34375189/ (In Vitro)
https://www.biorxiv.org/content/10.1101/2021.11.03.467186v1
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
https://pubmed.ncbi.nlm.nih.gov/32513797/
https://pubmed.ncbi.nlm.nih.gov/33674802/
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Mosharaf et al., Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing, Scientific Reports, doi:10.1038/s41598-022-08073-8
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Chen et al., Tafenoquine and its derivatives as inhibitors for the Severe Acute Respiratory Syndrome Coronavirus 2, Journal of Biological Chemistry, doi:10.1016/j.jbc.2022.101658
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sagulkoo et al., Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing, Biomolecules, doi:10.3390/biom12050690
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
https://pubmed.ncbi.nlm.nih.gov/33415017/
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Nandi et al., Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking, Letters in Drug Design & Discovery, doi:10.2174/1570180818666211007111105
Hicks et al., Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors, Bioorganic & Medicinal Chemistry Letters, doi:10.1016/j.bmcl.2022.128732
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Del Amo, J., Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers, medRxiv, doi:10.1101/2022.03.02.22271710
Polo et al., Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers, Clinical Microbiology and Infection, doi:10.1016/j.cmi.2022.07.006
Frediansyah et al., Antivirals for COVID-19: A critical review, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.07.006
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Rudrapal et al., Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations, Journal of King Saud University - Science, doi:10.1016/j.jksus.2022.101826
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
BHARDWAJ et al., Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex, Turkish Journal of Pharmaceutical Sciences, doi:10.4274/tjps.galenos.2021.56957
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0253489
Al-Sehemi et al., In Silico Exploration of Binding Potentials of Anti SARS-CoV-1 Phytochemicals against Main Protease of SARS-CoV-2, Journal of Saudi Chemical Society, doi:10.1016/j.jscs.2022.101453
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://ccforum.biomedcentral.com/articles/10.1186/s13054-021-03648-9 (Retrospective Study)
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8242279/
https://pubmed.ncbi.nlm.nih.gov/33817670/
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7428453/
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Yuan et al., Screening for inhibitors against SARS-CoV-2 and its variants, Biosafety and Health, doi:10.1016/j.bsheal.2022.05.002
Mosharaf et al., Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing, Scientific Reports, doi:10.1038/s41598-022-08073-8
Ramos-Zaldívar et al., A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19, medRxiv, doi:10.1101/2021.12.05.21267318
Abdallah et al., Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics, Plants, doi:10.3390/plants11151914
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Jang et al., Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2024302118
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://link.springer.com/article/10.1007/s12640-022-00542-2
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Heimfarth et al., Drug repurposing and cytokine management in response to COVID-19: A review, International Immunopharmacology, doi:10.1016/j.intimp.2020.106947
Polanco et al., Caracterización del uso de tofacitinib como tratamiento para covid-19, Revista Colombiana de Reumatología, doi:10.1016/j.rcreu.2022.03.002
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Pillaiyar et al., Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy, Journal of Medicinal Chemistry, doi:10.1021/acs.jmedchem.1c00335
https://trialsitenews.com/todos-medicals-antiviral-treatment-tollovir-reduces-covid-19-mor..
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Munshi et al., An open-labelled, randomised, controlled, proof of concept clinical trial to evaluate the efficacy of AYUSH interventions (Cap.Torchnil + Tab. Febcin) as add-on therapy in the clinical management of moderate Covid-19 patients, Journal of Ayurveda and Integrative Medicine, doi:10.1016/j.jaim.2022.100559
https://www.biorxiv.org/content/10.1101/2020.04.13.039917v3
Mosharaf et al., Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing, Scientific Reports, doi:10.1038/s41598-022-08073-8
https://link.springer.com/article/10.1007/s12640-022-00542-2
https://www.sciencedirect.com/science/article/pii/S2213422021000688
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Chang et al., Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses, Scientific Reports, doi:10.1038/s41598-021-87254-3
Saeedi-Boroujeni et al., Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial, Archives of Medical Research, doi:10.1016/j.arcmed.2022.03.002
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Alamgir et al., Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records, medRxiv, doi:10.1101/2021.03.22.21254110
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Yuan et al., Screening for inhibitors against SARS-CoV-2 and its variants, Biosafety and Health, doi:10.1016/j.bsheal.2022.05.002
Arunkumar et al., Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1921032
https://www.biorxiv.org/content/10.1101/2021.12.28.474326v1
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://elifesciences.org/articles/68165
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Vanhulle et al., Carbohydrate-Binding Protein from Stinging Nettle as Fusion Inhibitor for SARS-CoV-2 Variants of Concern, bioRxiv, doi:10.1101/2022.07.08.499297
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Moreno-Pérez et al., El ácido valproico podría ayudar en la lucha contra el COVID-19: un estudio de casos y controles, Neurología, doi:10.1016/j.nrl.2022.01.007
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sarkar et al., Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives, Frontiers in Pharmacology, doi:10.3389/fphar.2020.572870
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Riva et al., A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals, bioRxiv, doi:10.1101/2020.04.16.044016
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Wang et al., Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture, Communications Biology, doi:10.1038/s42003-022-03101-9
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Zhang et al., A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-020-00343-z
Uhomoibhi et al., Molecular modelling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins, Scientific African, doi:10.1016/j.sciaf.2022.e01279
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Issac et al., Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic, bioRxiv, doi:10.1101/2022.03.24.485618
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
https://www.sciencedirect.com/science/article/pii/S2590257122000062
Barberis et al., Understanding protection from SARS-CoV-2 using metabolomics, Scientific Reports, doi:10.1038/s41598-021-93260-2
Angeles-Agdeppa et al., Virgin coconut oil is effective in lowering C-reactive protein levels among suspect and probable cases of COVID-19, Journal of Functional Foods, doi:10.1016/j.jff.2021.104557
Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951
Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951
Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951
Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951
Pandya et al., Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
http://hdl.handle.net/10523/13405
http://hdl.handle.net/10523/13405
http://hdl.handle.net/10523/13405
MacFadden et al., Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications, Open Forum Infectious Diseases, doi:10.1093/ofid/ofac156
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://link.springer.com/article/10.1007/s12640-022-00542-2
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
Rani et al., Modern drug discovery applications for the identification of novel candidates for COVID-19 infections, Annals of Medicine and Surgery, doi:10.1016/j.amsu.2022.104125
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
https://www.mdpi.com/2304-8158/10/9/2084/htm
https://www.sciencedirect.com/science/article/pii/S2095809921004422
Wu et al., Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China, Frontiers in Pharmacology, doi:10.3389/fphar.2020.615287
Wu et al., Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China, Frontiers in Pharmacology, doi:10.3389/fphar.2020.615287
https://www.cureus.com/articles/43909-potential-role-of-xylitol-plus-grapefruit-seed-extra..
https://probiologists.com/Uploads/Articles/11_637497463703161509.pdf
https://www.biorxiv.org/content/10.1101/2020.12.02.408575v3.full.pdf
https://www.businesswire.com/news/home/20211222005383/en/
https://www.researchgate.net/publication/347176706_A_Nasal_Spray_Solution_of_Grapefruit_Se..
https://www.precisionvaccinations.com/nasal-spray-may-eliminate-sars-cov-2-virus
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Riva et al., A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals, bioRxiv, doi:10.1101/2020.04.16.044016
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
Mirabelli et al., Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2105815118
Chen et al., Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2, Frontiers in Pharmacology, doi:10.3389/fphar.2020.592737
https://link.springer.com/article/10.1007/s12640-022-00542-2
Lazniewski et al., Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations, Methods, doi:10.1016/j.ymeth.2022.02.004
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Qiao et al., Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2021450118
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Sperry et al., Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19, medRxiv, doi:10.1101/2022.04.12.22273802
Kladnik et al., Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication, bioRxiv, doi:10.1101/2022.03.03.482819
Manandhar et al., Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study, Structural Chemistry, doi:10.1007/s11224-022-01921-3
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Manandhar et al., Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study, Structural Chemistry, doi:10.1007/s11224-022-01921-3
Manandhar et al., Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study, Structural Chemistry, doi:10.1007/s11224-022-01921-3
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Kadioglu et al., Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104359
Power et al., Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein, Bioorganic Chemistry, doi:10.1016/j.bioorg.2021.105574
Power et al., Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein, Bioorganic Chemistry, doi:10.1016/j.bioorg.2021.105574
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Power et al., Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein, Bioorganic Chemistry, doi:10.1016/j.bioorg.2021.105574
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432
Nag et al., Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Askari et al., Digging for the Discovery of SARS-CoV-2 nsp12 Inhibitors: A Pharmacophore-Based and Molecular Dynamics Simulation Study, Research Square, doi:10.21203/rs.3.rs-907714/v1
https://link.springer.com/article/10.1007/s12640-022-00542-2
Sportelli et al., On the Efficacy of ZnO Nanostructures against SARS-CoV-2, International Journal of Molecular Sciences, doi:10.3390/ijms23063040
Hajdrik et al., In Vitro Determination of Inhibitory Effects of Humic Substances Complexing Zn and Se on SARS-CoV-2 Virus Replication, Foods, doi:10.3390/foods11050694
Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930
https://www.sciencedirect.com/science/article/pii/S1319562X21007968
https://www.biorxiv.org/content/10.1101/2021.10.29.466402v1
Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709
Arunkumar et al., Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1921032
Banitalebi et al., In silico study of potential immunonutrient-based sports supplements against COVID-19 via targeting ACE2 inhibition using molecular docking and molecular dynamics simulations, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.2016489
https://www.sciencedirect.com/science/article/pii/S0223523421007066
https://digitalcommons.pcom.edu/research_day/research_day_GA_2022/researchGA2022/20/
https://www.sciencedirect.com/science/article/pii/S0223523421007066
Uma Reddy et al., Multifaceted role of plant derived small molecule inhibitors on replication cycle of sars-cov-2, Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105512
Arunkumar et al., Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1921032
Padmi et al., Anti-inflammatory potential of λ-carrageenan by inhibition of IL-6 receptor: in silico study, IOP Conference Series: Earth and Environmental Science, doi:10.1088/1755-1315/913/1/012106
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit    
Share
Tweet
@CovidAnalysis
FAQ
Public domain CC0 1.0